59
Pharmacy Medical Policy Immune Modulating Drugs Table of Contents Policy: Commercial Information Pertaining to All Policies Endnotes Policy: Medicare References Forms Policy History Coding Information Policy Number: 004 BCBSA Reference Number: 5.01.15 Related Policies Quality Care Dosing guidelines may apply to the following medications and can be found in Medical Policy #621A. Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Note: All requests for outpatient retail pharmacy for indications listed and not listed on the medical policy guidelines may be submitted to BCBSMA Clinical Pharmacy Operations by completing the Prior Authorization Form on the last page of this document. Physicians may also call BCBSMA Pharmacy Operations department at (800)366-7778 to request a prior authorization/formulary exception verbally. Patients must have pharmacy benefits under their subscriber certificates. Please refer to the chart below for the formulary and step status of the medications affected by this policy and click on the hyperlink to get to the disease specific criteria. INFLIXIMAB Table ` Rheumatoid Arthritis Ankylosing Spondylitis Psoriatic Arthritis Psoriasis Crohn’s Disease Ulcerative Colitis Preferred Drugs Inflectra Inflectra Inflectra Inflectra Inflectra Inflectra % Non-Preferred Drugs (treatment failure required with 1 preferred drug) Renflexis Avsola Renflexis Avsola Renflexis Avsola Renflexis Avsola Renflexis Avsola Renflexis Avsola % Non-Preferred Drugs (treatment failure required with 2 preferred drugs) Remicade^^ Remicade^^ Remicade^^ Remicade^^ Remicade^^ Remicade^^ ^^- This Drug is part of Medications covered only under the pharmacy benefit program and Inflectra & Renflexis are required to be tried prior to its use. % - Inflectra & Renflexis were approved for 6 years of age or older with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.

004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

Pharmacy Medical Policy Immune Modulating Drugs

Table of Contents • Policy: Commercial • Information Pertaining to All Policies • Endnotes

• Policy: Medicare • References • Forms

• Policy History • Coding Information

Policy Number: 004 BCBSA Reference Number: 5.01.15

Related Policies • Quality Care Dosing guidelines may apply to the following medications and can be found in Medical

Policy #621A.

Policy

Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Note: All requests for outpatient retail pharmacy for indications listed and not listed on the medical policy guidelines may be submitted to BCBSMA Clinical Pharmacy Operations by completing the Prior Authorization Form on the last page of this document. Physicians may also call BCBSMA Pharmacy Operations department at (800)366-7778 to request a prior authorization/formulary exception verbally. Patients must have pharmacy benefits under their subscriber certificates. Please refer to the chart below for the formulary and step status of the medications affected by this policy and click on the hyperlink to get to the disease specific criteria.

INFLIXIMAB Table ` Rheumatoid

Arthritis Ankylosing Spondylitis

Psoriatic Arthritis

Psoriasis Crohn’s Disease

Ulcerative Colitis

Preferred Drugs

Inflectra

Inflectra

Inflectra Inflectra

Inflectra

Inflectra%

Non-Preferred Drugs (treatment failure required with 1 preferred drug)

Renflexis Avsola

Renflexis Avsola

Renflexis Avsola

Renflexis Avsola

Renflexis Avsola

Renflexis Avsola %

Non-Preferred Drugs (treatment failure required with 2 preferred drugs)

Remicade^^

Remicade^^

Remicade^^

Remicade^^

Remicade^^

Remicade^^

^^- This Drug is part of Medications covered only under the pharmacy benefit program and Inflectra & Renflexis are required to be tried prior to its use. % - Inflectra & Renflexis were approved for 6 years of age or older with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.

Page 2: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

Other Immune Modulating Drugs Table

` Rheumatoid Arthritis

Ankylosing Spondylitis

Juvenile Idiopathic Arthritis

Psoriatic Arthritis

Psoriasis Crohn’s Disease

Ulcerative Colitis

Preferred Drugs

Enbrel^ Humira^ Actemra Xeljanz / XR*$

Rinvoq*$

Enbrel^ Humira^ Cosentyx

Enbrel^ Humira^

Enbrel^ Humira^ Cosentyx Stelara^* Xeljanz / XR*$

Otezla**

Humira^ Skyrizi Otezla**

Tremfya Stelara^* Cosentyx

Humira^ Stelara^*

Humira^

Non-Preferred Drugs (treatment failure required with 1 preferred drug)

Actemra$

Enbrel^$

Cimzia** ^$ Entyvio

Simponi^ Entyvio Xeljanz*$

Stelara^*

Non-Preferred Drugs (treatment failure required with 2 preferred drugs)

Cimzia** ^ Kevzara Kineret^ Simponi^ Simponi Aria Rituxan** Olumiant Orencia

Cimzia** ^ Simponi Aria Simponi^

Orencia@

Ilaris^#

Cimzia** ^ Orencia Simponi^ Simponi Aria

Siliq Ilumya Cimzia** ^

Non-Preferred Drugs (treatment failure required with 3 preferred drugs)

Taltz^

Taltz^

Taltz^

Additional Diags

Hidradenitis Suppurativa

Panuveitis/Uveitis

CAPs Giant Cell Arteritis (GCA)

Preferred Drugs

Humira^ Humira^ Kineret^ Ilaris^#

Actemra

Non-Preferred Drugs

**NOTE: Other FDA Approved diagnoses not listed in the table for Rituxan®, Otezla®, Ilaris, or Cimzia will be covered without prior preferred biologics treatment failure requirements. ^ - This Drug is part of Medications covered only under the pharmacy benefit program ^# - This Drug is part of Medications covered only under the pharmacy benefit program and Other FDA Approved

Sticky Note
This Drug is part of Medications covered only under the pharmacy benefit program
Sticky Note
Oral Dosage form
Sticky Note
This drug has both a Sub Q version which is part of Medications covered only under the pharmacy benefit program and an IV version which is NOT part of the pharmacy only program and the Formulary placement is the same.
Sticky Note
Other FDA Approved diagnoses not listed in the table for Rituxan®, Otezla®, Ilaris, or Cimzia will be covered without prior preferred biologics treatment failure requirements.
Sticky Note
This Drug requires that Humira is to be tried prior to its use.
Sticky Note
Other FDA Approved diagnoses not listed in the table for Rituxan®, Otezla®, Ilaris, or Cimzia will be covered without prior preferred biologics treatment failure requirements. This Drug is part of Medications covered only under the pharmacy benefit program and Humira is required to be tried prior to its use.
Sticky Note
This Drug is part of Medications covered only under the pharmacy benefit program and Other FDA Approved
Sticky Note
This drug requires to the use of at least two Step 1 or two Step 2 or one Step 1 and one Step 2 prior to its use.
Page 3: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

diagnoses (FMF, MKD, TRAPS & HIDS) for Ilaris® will be covered without prior treatment failure requirements. ^* - This drug has both a Sub Q version which is part of Medications covered only under the pharmacy benefit program and an IV version which is NOT part of the pharmacy only program and the Formulary placement is the same. ^$- This Drug is part of Medications covered only under the pharmacy benefit program and Humira is required to be tried prior to its use. $- This Drug requires that Humira is to be tried prior to its use. @ - This drug requires to the use of at least two Step 1 or two Step 2 or one Step 1 and one Step 2 prior to its use. *$ - Oral Dosage form Ankylosing Spondylitis: We may cover Preferred Drugs*$ for adults (18 years and older) with active ankylosing spondylitis when ALL the following criteria are met:

• A documented diagnosis of active ankylosing spondylitis, • Treatment failure with or contraindication to one prescription NSAID within the past 130 days; AND • The drug is prescribed by a board-certified or board eligible rheumatologist; OR • The patient had previous use of a Preferred Drug within the previous 130 days. We may cover Non-Preferred Drugs for adults with active ankylosing spondylitis when ALL the following criteria are met: • A documented diagnosis of active ankylosing spondylitis, • Treatment failure with one prescription NSAID within the past 130 days; AND • The drug is prescribed by a board-certified or board eligible rheumatologist; AND • There has been previous treatment failure with TWO*$$ Preferred Drugs within the previous 130 days. *$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage. *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Crohn’s Disease: We may cover Preferred Drugs adults and Children (6 years and older) with moderately to severely active Crohn’s Disease when ALL the following criteria are met:

• A documented diagnosis of moderately to severely active Crohn’s Disease, • Treatment failure with or contraindication to 2 or more of the following drugs within the previous 130

days: o Corticosteroids (e.g. prednisone, prednisolone, methylprednisolone, budesonide) o 5-Aminosalicylates (e.g. sulfasalazine, mesalamine, olsalazine, balsalazide) o Immunosuppressants / Immunomodulators (e.g. 6-mercaptopurine, azathioprine, methotrexate);

AND • The drug is prescribed by a board-certified or board eligible gastroenterologist; OR • The patient had previous use of a Preferred Drug within the previous 130 days. We may cover Non-Preferred Drugs*$ for adults and Children (6 years and older) with moderately to severely Active Crohn’s Disease when ALL the following criteria are met: • A documented diagnosis of moderately to severely active Crohn’s Disease, • Treatment failure with or contraindication to 2 or more of the following drugs within the previous 130

days: o Corticosteroids (e.g. prednisone, prednisolone, methylprednisolone, budesonide)

Page 4: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

o 5-Aminosalicylates (e.g. sulfasalazine, mesalamine, olsalazine, balsalazide) o Immunosuppressants / Immunomodulators (e.g. 6-mercaptopurine, azathioprine, methotrexate);

AND • The drug is prescribed by a board-certified or board eligible gastroenterologist; AND • There has been previous treatment failure with ONE Preferred Drugs within the previous 130 days. *$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Cryopyrin-associated periodic syndromes (CAPS): We may cover Preferred Drugs adults and Children (4 years and older) with cryopyrin-associated periodic syndromes (CAPS) including familial cold autoinflammatory syndrome (FCAS) and Muckle-Wells syndrome when ALL the following criteria are met:

• A documented diagnosis of cryopyrin-associated periodic syndrome (CAPS), familial cold autoinflammatory syndrome (FCAS) or Muckle-Wells syndrome,

• The drug is prescribed by a board-certified or board-eligible rheumatologist or dermatologist. Return to Drug Table Giant Cell Arteritis (GCA): We may cover Preferred Drugs adults (18 years and older) with Giant Cell Arteritis when ALL the following criteria are met:

• A documented diagnosis of Giant Cell Arteritis. Return to Drug Table Hidradenitis Suppurativa: We may cover Preferred Drugs adults (12 years and older) with moderately to severely active hidradenitis suppurativa when ALL the following criteria are met:

• A documented diagnosis of moderately to severely active hidradenitis suppurativa, Return to Drug Table Juvenile Idiopathic Arthritis: We may cover Preferred Drugs for children (2 years and older) with moderately to severely active juvenile idiopathic arthritis, when ALL the following criteria are met:

• A documented diagnosis moderately to severely active juvenile idiopathic arthritis; AND • The drug is prescribed by a board-certified or board eligible rheumatologist; OR • The patient had previous use of a Preferred Drug within the previous 130 days. We may cover Non-Preferred Drugs*$ for children (2 years and older) with moderately to severely active juvenile idiopathic arthritis, when ALL the following criteria are met: • A documented diagnosis of active moderately to severely active juvenile idiopathic arthritis, AND • The drug is prescribed by a board-certified or board eligible rheumatologist; AND • There has been previous treatment failure with TWO*$$ Preferred Drugs within the previous 130 days.

Page 5: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

*$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage. *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Panuveitis/Uveitis We may cover Preferred Drugs for 2 years and older with moderate non-infectious intermediate, posterior Uveitis and Panuveitis when ALL the following criteria are met:

• A documented diagnosis of non-infectious intermediate, posterior and panuveitis, AND • Treatment failure in claims history with or contraindication to one of the following drug classes within the

previous 130 days: o topical therapy with corticosteroids o topical therapy with cycloplegics

OR • The patient had previous use of a Preferred Drug within the previous 130 days. Return to Drug Table Psoriasis We may cover Preferred Drugs for adults and children (6 years and older) with moderate to severe chronic plaque psoriasis when ALL the following criteria are met:

• A documented diagnosis of moderate to severe chronic plaque psoriasis, • Treatment failure with or contraindication to one course of systemic therapy for psoriasis within the last

130 days, such as, but not limited to: o Methotrexate o Azathioprine o Acitretin o Tacrolimus o Cyclosporine o Mycophenolate mofetil o 6-thioguanine o Sulfasalazine o Hydroxyurea o Propylthiouracil o Oral methoxsalen plus UVA light (PUVA); o Narrow-band -UVB Treatment

AND • The drug is prescribed by a board-certified or board eligible dermatologist; OR • The patient had previous use of a Preferred Drug within the previous 130 days. We may cover Non-Preferred Drugs*$ for adults and children (4%% years and older) with severe plaque psoriasis when the following criteria are met: • A documented diagnosis of severe plaque psoriasis, • Treatment failure with or contraindication to one course of systemic therapy for psoriasis within the last

130 days, such as, but not limited to: o methotrexate o azathioprine o acitretin o tacrolimus o cyclosporine o mycophenolate mofetil

Page 6: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

o 6-thioguanine o sulfasalazine o hydroxyurea o propylthiouracil o oral methoxsalen plus UVA light (PUVA); o Narrow-band -UVB Treatment

AND • The drug is prescribed by a board-certified or board eligible dermatologist; AND • There has been previous treatment failure with TWO*$$ Preferred Drugs within the previous 130 days. *$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage. %% - Currently only one medication (etanercept) is approved for children between the ages of 4-6 years of age and will be treated as preferred for children as long as preferred medication(s) do not have FDA approval for that age. *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Psoriatic Arthritis We may cover Preferred Drugs for active psoriatic arthritis when ALL the following criteria are met:

• A documented diagnosis of active psoriatic arthritis, • Treatment failure with or contraindication to one oral or injectable DMARD1 agent within the past 130

days; AND • The drug is prescribed by a board-certified or board eligible rheumatologist; OR • The patient had previous use of a Preferred Drugs within the previous 130 days. We may cover Non-Preferred Drugs*$ for active psoriatic arthritis when ALL the following criteria are met: • A documented diagnosis of active psoriatic arthritis; AND • Treatment failure with or contraindication to one oral or injectable DMARD¹ agent within the past 130

days; AND • The drug is prescribed by a board-certified or board eligible rheumatologist; AND • There has been previous treatment failure with TWO*$$ Preferred Drugs within the previous 130 days. *$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage. *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Rheumatoid Arthritis We may cover Preferred Drugs for adults (18 years and older) with rheumatoid arthritis when ALL the following criteria are met:

• A documented diagnosis of adult moderately to severely active rheumatoid arthritis, AND • Treatment failure with, or contraindication to one traditional DMARD1 agent within the last 130 days, AND • The drug is prescribed by a board-certified or board eligible rheumatologist. We may cover Non-Preferred Drugs*$ for adults (18 years and older) with rheumatoid arthritis when ALL the following criteria are met:

Page 7: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

• A documented diagnosis of adult moderately to severely active rheumatoid arthritis, • Treatment failure with, or contraindication to one traditional DMARD1 agent within the last 130 days, • Treatment failure with or contraindication to TWO*$$ Preferred Drugs within the last 130 days, • The drug is prescribed by a board-certified or board eligible rheumatologist. *$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage. *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Ulcerative Colitis We may cover Preferred Drugs for adults (18 years and older) with moderately to severely active Ulcerative Colitis when ALL the following criteria are met:

• A documented diagnosis of moderately to severely active Ulcerative Colitis, • Treatment failure with or contraindication to 2 or more of the following drugs within the previous 130

days: o Corticosteroids (e.g. prednisone, prednisolone, methylprednisolone) o 5-Aminosalicylates (e.g. sulfasalazine, mesalamine, olsalazine, balsalazide) o Immunosuppressants / Immunomodulators (e.g. 6-mercaptopurine, azathioprine, cyclosporine)

• The drug is prescribed by a board-certified or board eligible gastroenterologist; OR • The patient had previous use of a Preferred Drug within the previous 130 days. We may cover Non-Preferred Drugs*$ for adults (18 years and older) with moderately to severely active Ulcerative Colitis when ALL the following criteria are met: • A documented diagnosis of moderately to severely active Ulcerative Colitis, • Treatment failure with or contraindication to 2 or more of the following drugs within the previous 130

days: o Corticosteroids (e.g. prednisone, prednisolone, methylprednisolone) o 5-Aminosalicylates (e.g. sulfasalazine, mesalamine, olsalazine, balsalazide) o Immunosuppressants / Immunomodulators (e.g. 6-mercaptopurine, azathioprine, cyclosporine);

• The drug is prescribed by a board-certified or board eligible gastroenterologist; AND • The patient had previous use of ONE Preferred Drugs within the previous 130 days. *$ - Drugs which are still on the formulary but are non-preferred require the use of a single preferred Drug before they are eligible for coverage. *$$ - Where applicable and please see table above for any exceptions. Return to Drug Table Other Information Blue Cross Blue Shield of Massachusetts (BCBSMA*) members (other than Medex®; Blue MedicareRx, Medicare Advantage plans that include prescription drug coverage) will be required to fill their prescriptions for the above medications at one of the providers in our retail specialty pharmacy network, see link below: Link to Specialty Pharmacy List Individual Consideration All our medical policies are written for the majority of people with a given condition. Each policy is based on medical science. For many of our medical policies, each individual’s unique clinical circumstances may be considered in light of current scientific literature. Physicians may send relevant clinical information for individual patients for consideration to: Blue Cross Blue Shield of Massachusetts Pharmacy Operations Department

Page 8: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

25 Technology Place Hingham, MA 02043 Tel: 1-800-366-7778 Fax: 1-800-583-6289

Managed Care Authorization Instructions • Prior authorization is required for all out patient sites of service • For retail pharmacy requests, physicians may call BCBSMA Pharmacy Operations department to request

a review for prior authorization for patients. Pharmacy Operations: (800)366-7778

• For all outpatient sites of service requesting retail pharmacy exceptions, physicians may also fax or mail the attached form to the address above. The Formulary Exception/Prior Authorization form is included as part of this document for physicians to submit for patients.

PPO and Indemnity Authorization Instructions • Prior authorization is required when these medications are processed under the retail pharmacy benefit

and home infusion therapy benefit. • Prior authorization is not required when drugs are not part of Pharmacy only program and are purchased

by the physician and administered in the office. • For retail pharmacy requests, physicians may call BCBSMA Pharmacy Operations department to request

a review for prior authorization for patients. Pharmacy Operations: (800)366-7778

• Physicians may also fax or mail the attached form requesting retail pharmacy exceptions to the address above. The Formulary Exception/Prior Authorization form is included as part of this document for physicians to submit for patients.

Policy History Date Action 9/2020 Updated to add Avsola to the Infliximab table and Stelara’ s new age for psoriasis. 6/2020 Updated to move Otezla to preferred for psoriatic arthritis. 2/2020 Updated to move Stelara to move to non-preferred for UC. 1/2020 Updated to move Taltz in all indications and Xeljanz in UC indication to non-preferred. 10/2019 Updated to add Rinvoq to preferred RA and to add expanded indications for Inflectra,

Renflexis & Otezla. 7/2019 Updated to add Skyrizi & Tremfya to preferred in Psoriasis and to add Humira first step to

Cimzia for Crohn’s disease. 1/1/2019 Updated to Add an Infliximab table and make Inflectra a Preferred drug for its indications.

Moved Xeljanz /XR to preferred status for all indications. Clarified coding information 10/2018 Updated to add Ilumya and Olumiant to a non-preferred position in the policy. 7/2018 Update to include additional Criteria for Remicade. 2/2018 Update to add Stelara to Preferred in Crohn’s, Xeljanz to Psoriatic Arthritis non-preferred

and added Tremfya to requiring Humira first instead of two covered alternatives. 1/2018 Clarified coding information and updated to include Tremfya & Siliq as Non-Preferred

medications to the policy. 11/2017 Updated to add Kevzara to this policy and add new indications plus update Walgreens

specialty. 10/2017 Updated to include Renflexis. 7/2017 Update to include new indications for Actemra and Orencia. 6/2017 Update Address for Pharmacy Operations. 5/2017 Updated to Add hyperlinks for disease states in the medication table to link to specific

criteria in the policy. 1/1/2017 Updated criteria to be arranged by diagnosis instead by drug. 10/2016 Updated to add Taltz and to add new Q code for Infliximab. 4/2016 Updated to include new diagnosis and coding for Humira & Cosentyx. 1/2016 Clarified coding information. 10/2015 Updated to included revised language for Pharmacy only medications.

Page 9: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

7/2015 Updated to clarify Cosentyx placement and Rituxan® IC criteria. Clarified coding information.

4/2015 Updated to include Cosentyx. 1/2015 Update Criteria for Orencia For PJIA. 10/2014 Updated to include Otezla (apremilast) and updated to include Entyvio. 7/2014 Updated to include ICD-10. 2/2014 Added some already coded ICD9s.(i.e. 556.0). Diagnoses codes: 555.3, 555.4, 555.5,

555.6, 555.7 and 555.8 were previously listed in error as covered diagnoses and have been removed to coincide with system edits that remain unchanged.

1/2014 Updated to include new UC indication for Simponi, Stelara and add Xeljanz criteria. Removed Blue Value Formulary information. Added Enbrel and Humira where indication appropriate. Updated ExpressPAth language. Updated Reference 1.

1/2013 Updated 1/2013 to include new FDA approved indication for Actemra® of systemic juvenile idiopathic arthritis.

4/2012 Updated with specialty pharmacy contact information. 11/2011-4/2012

Medical policy ICD 10 remediation: Formatting, editing and coding updates. No changes to policy statements.

1/2012 Updated with specialty pharmacy contact information. 11/2011 Reviewed - Medical Policy Group - Plastic Surgery and Dermatology.

No changes to policy statements. 11/2010 Reviewed - Medical Policy Group - Gastroenterology, Nutrition and Organ

Transplantation. No changes to policy statements.

9/2010 Updated to include coverage criteria for new FDA approved products based on P&T Committee recommendations: Actemra, Ilaris, and Stelara and update of specialty pharmacy contact information.

7/2010 Reviewed - Medical Policy Group - Orthopedics, Rehabilitation Medicine and Rheumatology. No changes to policy statements.

1/2010 Policy updated to include coverage criteria for new drug Simponi®, add new PDA approved diagnosis of rheumatoid arthritis to coverage criteria for Cimzia®, and to add additional coverage criteria to certain Remicade diagnoses®.

12/2009 Reviewed - Medical Policy Group - Plastic Surgery and Dermatology. No changes to policy statements.

10/2009 Policy updated to reflect UM requirements and remove Raptiva from medical policy. 9/2009 Policy updated to change 180 day look back period to 130 days and to remove Medicare

Part D criteria from Medical Policy. 7/2009 Reviewed - Medical Policy Group - Orthopedics, Rehabilitation Medicine and

Rheumatology. No changes to policy statements.

1/2009 Updated to include coverage criteria for Rituxan® for rheumatoid arthritis and to combine coverage criteria for plaque psoriasis diagnoses for Amevive® , Enbrel ®, Humira®, Raptiva™ and Remicade® (Taken from Medical Policy #020 which will be retired on 1/1/09.)

10/2008 Updated to include covered indication for Cimzia®. 7/2008 Reviewed - Medical Policy Group - Orthopedics, Rehabilitation Medicine and

Rheumatology. No changes to policy statements.

5/2008 Updated to include new indication for Orencia® for juvenile idiopathic arthritis. 3/2008 Updated to include new indication for Humira™ for juvenile idiopathic arthritis. 2/2008 Updated to include additional retail specialty pharmacy network information. 11/2007 Reviewed - Medical Policy Group - Gastroenterology, Nutrition and Organ

Transplantation. No changes to policy statements.

7/2007 Reviewed - Medical Policy Group - Orthopedics, Rehabilitation Medicine and Rheumatology. No changes to policy statements.

5/2007 Updated to include FDA-approved indication for Humira (adalimumab) for Crohn’s Disease and Ankylosing Spondylitis.

1/2007 Updated to include coverage for FDA-approved indication for Remicade for Pediatric

Page 10: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

Crohn’s Disease and retail specialty pharmacy network information. 10/2004 New policy, effective 10/2004, describing covered and non-covered indications.

References 1. 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of 2. Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis.

Arthritis Care & Research Vol. 64, No. 5, May 2012, pp 625–639. 3. Ledingham J. Deighton C; British Society for Rheumatology Standards, Guidelines and Audit Working

Group. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford). 2005;44:157-163. Epub 2005 Jan 5.

4. Enbrel [package insert]. Seattle, WA: Immunex September 2011. Manufactured by: Immunex Corporation Thousand Oaks, CA 91320-1799 Marketed by Amgen Inc. and Pfizer Inc.

5. Humira injection [package insert]. North Chicago, IL: Abbie V Inc.; May 2013. 6. Kineret injection [package insert]. C/O Quintiles, Inc. 18518 Cornflower Road Boyds, MD 20841.

Swedish Orphan Biovitrum AB. December 2012. 7. Remicade for intravenous infusion [package insert]. Malvern, PA 19335. Janssen Biotech, Inc. March

2013. 8. Orencia™ [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; September 2011. 9. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor α

monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate. The ARMADA trial. Arthritis Rheum. 2003;48:35-45.

10. Van de Putte LBA, Atkins C, Malaise M, et al. Adalimumab (D2E7) monotherapy in the treatment of patients with severely active rheumatoid arthritis [abstract]. Presented at: American College of Rheumatology 66th Annual Scientific Meeting; October 25–29, 2002; New Orleans, LA.

11. Cohen S, Hurd E, Cush J, et al. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate. Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46:614-624.

12. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med. 1999;130:478-486.

13. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. NEJM. 1999;340:253-259.

14. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. NEJM. 2000;343:1586-1593.

15. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum. 2002;46:1443-1450.

16. Genovese MC, Martin RW, Fleischmann RM, et al. Etanercept (Enbrel®) in early erosive rheumatoid arthritis (ERA Trial): observations at 4 years [abstract]. Presented at: American College of Rheumatology 66th Annual Scientific Meeting; October 25–29, 2002; New Orleans, LA.

17. Moreland LW, Cohen SB, Baumgartner SW, et al. Etanercept (Enbrel®) monotherapy for more than 5 years in patients with DMARD-refractory rheumatoid arthritis [abstract]. Presented at: American College of Rheumatology 66th Annual Scientific Meeting; October 25–29, 2002; New Orleans, LA.

18. Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics. 2002;109:109-115. 19. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid

arthritis. NEJM. 2000;342:763-769. 20. Lovell DJ, Giannini EH, Reiff A, et al for the Pediatric Rheumatology Collaborative Study Group. Long-

term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003;48:218-226.

21. Kietz DA, Pepmueller PH, Moore TL. Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period. Ann Rheum Dis. 2002;61:171-173.

22. Haapasaari J, Kautiainen H, Hannula S, et al. Good results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritis. Clin Exp Rheumatol. 2002;20:867-870.

23. Russo RA, Katsicas MM, Zelazko M. Etanercept in systemic juvenile idiopathic arthritis. Clin Exp Rheumatol. 2002;20:723-726.

24. Khan MA, Update on spondyloarthropathies. Ann Intern Med. 2002;136:896-907. 25. Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 2002;62:2447-

2457.

Page 11: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

26. Jones G, Crotty M, Brooks P, and the Psoriatic Arthritis Meta-Analysis Study Group. Psoriatic arthritis: a quantitative overview of therapeutic options. Br J Rheumatol. 1997;36:95-99.

27. Mease PJ, Goffe BS, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet. 2000;356:385-390.

28. Mease P, Kivitz A, Burch F, et al. Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial [abstract 226]. Presented at: American College of Rheumatology – 65th Annual Scientific Meeting; November 12-15, 2001; San Francisco, CA.

29. Ory P, Sharp JT, Salonen D, et al. Etanercept (Enbrel®) inhibits radiographic progression in patients with psoriatic arthritis. Abstracts from American College of Rheumatology – 66th Annual Scientific Meeting; October 25-29, 2002; New Orleans, LA.

30. Davis JC Jr, Van Der Heijde D, Braun J, et al. Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum. 2003; 48: 3230-3236.

31. Gorman JD, Sack KE, Davis Jr JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. NEJM. 2002;346:1349-1356. [correction NEJM. 2003;348;360-361.]

32. Brandt J, Kariouzov A, Listing J, et al. Six months results of a German double-blind placebo controlled, phase-III clinical trial of etanercept in active ankylosing spondylitis. Abstracts from American College of Rheumatology – 66th Annual Scientific Meeting; October 25-29, 2002; New Orleans, LA.

33. Toussirto E, Wendling D. Current guidelines for the drug treatment of ankylosing spondylitis. Drugs. 1998;56:225-240.

34. Braun J, Sieper J, Breban M, et al. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Ann Rheum Dis. 2002;61 Suppl 3:iii51-60.

35. Cummins C, Connock M, Fry-Smith A, et al. A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. Health Technol Assess. 2002;6:1-43.

36. Keystone E, Kavanaugh AF, Sharp J, et al. Adalimumab (D2E7), a fully human anti-TNF-α monoclonal antibody, inhibits the progression of structural joint damage in patients with active RA despite concomitant methotrexate therapy [abstract]. Presented at: American College of Rheumatology 66th Annual Scientific Meeting; October 25–29, 2002; New Orleans, LA.

37. Furst DE, Schiff M, Fleischmann R, et al. Safety and efficacy of adalimumab (D2E7), a fully human anti-TNF-α monoclonal antibody, given in combination with standard antirheumatic therapy: safety trial of adalimumab in rheumatoid arthritis (STAR) [abstract]. Presented at: American College of Rheumatology 66th Annual Scientific Meeting; October 25–29, 2002; New Orleans, LA.

38. van Riel PLC, van de Putte LBA, Rau R, et al. Long-term treatment with adalimumab (D2E7) using background methotrexate in active rheumatoid arthritis: results of a 3 year study [abstract]. Presented at: American College of Rheumatology 66th Annual Scientific Meeting; October 25–29, 2002; New Orleans, LA.

39. Cohen SB, Moreland LW, Cush JJ, et al. Anakinra (recombinant interleukin-1 receptor antagonist): a large, placebo controlled efficacy trial of anakinra in patients with erosive rheumatoid arthritis disease. Presented at: American College of Rheumatology 65th Annual Scientific Meeting; November 11-15, 2001; San Francisco, CA. Arthritis Rheum. 2001;44 (suppl):Abstract LB-1.

40. Bresnihan B, Alvaro-Gracia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998;41:2196-2204.

41. Nuki G, Bresnihan B, Bear MB, et al for the European Group of Clinical Investigators. Lone-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patient with rheumatoid arthritis. Extension phase of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002;46:2838-2846.

42. Jiang Y, Genant HK, Watt I, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 2000;43:1001-1009.

43. Cohen SB, Woolley JM, Chan WW for the Anakinra 960180 Study Group. Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis. J Rehumatol. 2003;30:225-231.

44. Lipsky PE, van der Heijde DM, St Clair EW, et al Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. NE JM. 2000;343:1594-1602.

Page 12: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

45. Maini R, St Clair EW, Breedveld F, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. Lancet. 1999;354:1932-1939.

46. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. NE JM. 1997;337:1029-1035.

47. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn’s disease: the Accent I randomized trial. Lancet. 2002;359:1541-1549.

48. Rutgeerts P, D’Haens G, Targan S, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn’s disease. Gastroenterology. 1999;117:761-769.

49. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol. 2002;97:2962-2972.

50. Stephens MC, Shepanski MA, Mamula P, et al. Safety and steroid-sparing experience using infliximab for Crohn’s disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol. 2003;98:104-111.

51. Hyams JS. Use of infliximab in the treatment of Crohn's disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2001;33 Suppl 1:S36-39.

52. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. NEJM. 1999;340:1398-1405.

53. Toussirto E, Wendling D. Current guidelines for the drug treatment of ankylosing spondylitis. Drugs. 1998;56:225-240.

54. Gorman JD, Sack KE, Davis Jr JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. NEJM. 2002;346:1349-1356. [correction NEJM. 2003;348;360-361.]

55. Brandt J, Kariouzov A, Listing J, et al. Six months results of a German double-blind placebo controlled, phase-III clinical trial of etanercept in active ankylosing spondylitis. Abstracts from American College of Rheumatology – 66th Annual Scientific Meeting; October 25-29, 2002; New Orleans, LA.

56. Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 2002;62:2447-2457.

57. Jones G, Crotty M, Brooks P, and the Psoriatic Arthritis Meta-Analysis Study Group. Psoriatic arthritis: a quantitative overview of therapeutic options. Br J Rheumatol. 1997;36:95-99.

58. Mease PJ, Goffe BS, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet. 2000;356:385-390.

59. Mease P, Kivitz A, Burch F, et al. Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial [abstract 226]. Presented at: American College of Rheumatology – 65th Annual Scientific Meeting; November 12-15, 2001; San Francisco, CA.

60. Ory P, Sharp JT, Salonen D, et al. Etanercept (Enbrel®) inhibits radiographic progression in patients with psoriatic arthritis. Abstracts from American College of Rheumatology – 66th Annual Scientific Meeting; October 25-29, 2002; New Orleans, LA.

61. Lahdenne P, Vahasalo P, Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis. 2003 Mar;62:245-247.

62. Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics. 2002;109:109-115. 63. Rutgeerts P, Feagan BF, Olson A, et al. A randomized placebo-controlled trial of infliximab for active

ulcerative colitis: Act 1 trial. Gastroenterology. 2005;128:A-105 (abstract). 64. Sandborn WJ, Rachmilewitz D, Hanauer S, et al. Infliximab induction and maintenance therapy for

ulcerative colitis: the Act 2 trial. Gastroenterology. 2005;128:A-104 (abstract). 65. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology.

Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.

66. Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology. 2005;128:1805-1811.

67. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. NEJM 2005 353;23:2462-2476.

68. Nash P, Clegg DO. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis. 2005;64 Suppl 2:ii74

69. Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 2002;62:2447-2457.

70. Mease PJ, Gladman DD, Ritchlin CT, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled. Arthritis Rheum. 2005;52:3279-3289.

Page 13: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

71. Mease PJ, Gladman DD, Ritchlin CT, et al. Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT. Arthritis Rheum. 2005;52(Suppl 9):S215.

72. Mease PJ, Sharp J, Ory P, et al. Inhibition of joint destruction in PsA with adalimumab: 48-week results of ADEPT. Arthritis Rheum. 2005;52(Suppl 9):S63.

73. Genovese MC, Becker JC, Schiff M, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med. 2005;353:1114-1123.

74. Kremer JM, Dougados M, Emery P, et al. Treatment of rheumatoid arthritis with the selective co stimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005;52:2263-2271.

75. Kremer JM, Westhovens R, Leon M, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4lg. N Engl J Med. 2003;349:1907-1915.

76. Kremer J, Westhovens R, Abud-Mendoza C, et al. Abatacept improves American College of Rheumatology responses and Disease Activity Score 28 remission rates in both recent-onset and more established rheumatoid arthritis: results of the AIM trial. Arthritis Rheum. 2005;52(Suppl):S562.

77. Russell A, Kremer J, Zhou Y, et al. Abatacept induces sustained improvements in physical function and pain over 3 years in rheumatoid arthritis patients with inadequate responses to methotrexate. Arthritis Rheum. 2005;52(Suppl):S659.

78. Russell A. Sherrer Y, Westhovens R, et al. Abatacept is effective at reducing pain and fatigue, and improving sleep quality in rheumatoid arthritis patients with an inadequate response to anti-TNF therapy in the ATTAIN trial. Ann Rheum Dis. 2005;64(Suppl III):397.

79. Moreland LW, Alten R, Van den Bosch F, et al. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4lg and LEA29Y eighty-five days after the first infusion. Arthritis Rheum. 2002;46:1470-1479.

80. Anon. A phase II study of abatacept versus placebo to assess the prevention of rheumatoid arthritis (RA) in adult patients with undifferentiated arthritis who are at high risk for the development of RA. US National Institutes of Health. Available at: http://www.clinicaltrials.gov/ct/show/NCT00124449?order=30 Accessed 01/04/2006.

81. Cimzia [package insert]. Symrna, GA: UCB, Inc.; Arpil 2008. 82. Rituxan injection [package insert]. South San Francisco, CA: Genentech, Inc; February 21, 2007. 83. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for

the management of rheumatoid arthritis. Arthritis Rheum. 2002;46:328-346 84. Smolen JS, Keystone EC, Emery P, et al; Working Group on the Rituximab Consensus Statement.

Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2007; 66:143-150

85. Food and Drug Administration, “Center for Drug Evaluation and Research, Office of Drug Safety Annual Report FY2004, “http://www.fda.gov/cder/Offices/ODS/annRep2004/default.htm.

86. Gordon KB, Leonardi C, Harvey D, et al. Continuous treatment improves outcomes in patients with moderate to severe plaque psoriasis treated with efalizumab (anti-CD11a). Results from the Phase III trial ACD2058g. Poster presented at the 60th Annual Meeting of the American Academy of Dermatology. February 2002. New Orleans, LA.

87. Data on file. South San Francisco, CA: Genentech. 88. Lebwohl M, Miller JL, Goldman M, et al. Continued treatment with subcutaneous efalizumab (anti-

CD11a) improves outcome in patients with moderate to severe plaque psoriasis. Poster presented at the 60th Annual Meeting of the American Academy of Dermatology. February 2002, New Orleans, LA.

89. Gordon KB, Siegfried E, Carey W, et al. Impact of 24 weeks of continuous efalizumab therapy on patient-reported outcomes in patients with moderate to severe plaque psoriasis. Poster presented at the Academy 2003 of the American Academy of Dermatology; July 25-29, 2003, Chicago, IL.

90. Gordon KB, Toth D, Papp KA, et al. Efalizumab provides rapid clinical benefit for patients with moderate to severe plaque psoriasis. Poster presented at the 9th International Psoriasis Symposium; June 18-22, 2003; New York, NY.

91. Gottlieb AB, Menter A, Duvic M, et al. Efalizumab (anti-CD11a) induction and maintenance treatment during a 12-month trial in patients with moderate to severe plaque psoriasis: preliminary findings. Poster presented at the 60th Annual Meeting of the American Academy of Dermatology. February 2002, New Orleans, LA.

92. Gottlieb AB, Gordon KB, Wallcke PA, et al. Continuous efalizumab therapy safely maintains psoriasis area and severity index improvement: preliminary results from an open-label trial. Poster presented at the 9th International Psoriasis Symposium; June 18-22, 2003; New York, NY.

93. Gottlieb AB, Gordon KB, Koo JY, et al. Long-term efalizumab treatment maintains clinical benefit in patients with moderate to severe plaque psoriasis: updated findings from an open-label trial. Poster presented at the Academy 2003 of the American Academy of Dermatology; July 25-29, 2003, Chicago, IL.

Page 14: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

94. Gordon KB, Tyring SK, Hamilton TK, et al. Examining duration of response and rebound during treatment with efalizumab (anti-CD11a). Poster presented at the 61st Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco, CA.

95. Gottlieb AB, Miller B, Lowe N, et al. Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasis. J Cutan Med Surg. 2003;7:198-207.

96. Gauvreau GM, Becker AB, Boulet L-P, et al. The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol. 2003;112:331-338.

97. American Academy of Dermatology. Guidelines of care for psoriasis. Committee on Guidelines of Care. Task Force on Psoriasis. J Am Acad Dermatol. 1993;28:632-637. Available at: http://www.aadassociation.org/Guidelines/psoriasis.html. Accessed 11/14/2003.

98. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 2001;45:487-498.

99. Peters BP, Weissman FG, Gill MA. Pathophysiology and treatment of psoriasis. Am J Health-Syst Pharm. 2000;57:645-662.

100. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001;45:649-661.

101. Iyer S, Yamauchi P, Lowe NJ. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol. 2002;146:118-121.

102. Weinberg JM, Saini R. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept. Cutis. 2003;71:25-29.

103. Gottlieb AB, Chaudhari U, Mulcahy LD, et al. Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis. J Am Acad Dermatol. 2003;48:829-835.

104. Ellis CN, Krueger GG, for the Alefacept Clinical Study Group. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med. 2001;345:248-255.

105. Krueger GG, Papp KA, Stough DB, for the Alefacept Clinical Study Group. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2002;47:821-833.

106. Cimzia® [package insert]. Smyrna, GA: UCB, Inc.; October, 2013. 107. Simponi® [package insert]. Horsham, PA: Janssen Biotech Inc.; Jan 2013. 108. Ilaris® [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; May, 2013. 109. Actemra® [package insert]. South San Francisco, CA: Genentech, Inc. Member of Roche Group;

October, 2013. 110. Stelara™ [package insert]. Horsham, PA: Janssen Biotech, Inc.; September 2013. 111. Xeljanz® [package insert]. New York, NY: Pfizer Inc.; November 2012. 112. Arthritis Care & Research. Vol. 64, No. 5, May 2012, pp 625–639. DOI 10.1002/acr.21641. © 2012,

American College of Rheumatology 2012 Update of the 2008 Americian College of Rhumatology Recommendations for the Use of Disease-Modifying Antirhumatic Drugs and Biologic Agents in the Treatment of Rhumatoid Arthritis, Singh et.al.

113. Arthritis & Rheumatism Vol. 65, No. 10, October 2013, pp 2499–2512. 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis

114. Simponi® AriaTM[package insert]. Horsham, PA: Janssen Biotech Inc.; Jan 2013. 115. Otexla® [package insert]. Summit, NJ: Celgene Corporation.; Mar 2014. 116. Cosentyx™ [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation.: 01/2015. 117. Taltz™ [package insert]. Indianapolis, IN: Eli Lilly and Company; 05/2016. 118. Kevzara® [package insert]. Bridgewater, NJ: sanofi-aventis U.S. LLC; 05/2017. 119. Olumiant® [package insert]. Indianapolis, IN: Eli Lilly and Company; 05/2018. 120. Ilumya™ [package insert]. Cranbury, NJ: Sun Pharmaceutical Industries, Inc.; Aug 2018.

CPT Codes / HCPCS Codes / ICD Codes Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. Please refer to the member’s contract benefits in effect at the time of service to determine coverage or non-coverage as it applies to an individual member. Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable. The following codes are included below for informational purposes only; this is not an all-inclusive list.

Page 15: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes HCPCS codes: Code Description J3262 Injection, tocilizumab, 1 mg (Actemra®)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description M05.00 Felty's syndrome, unspecified site M05.011 Felty's syndrome, right shoulder M05.012 Felty's syndrome, left shoulder M05.019 Felty's syndrome, unspecified shoulder M05.021 Felty's syndrome, right elbow M05.022 Felty's syndrome, left elbow M05.029 Felty's syndrome, unspecified elbow M05.031 Felty's syndrome, right wrist M05.032 Felty's syndrome, left wrist M05.039 Felty's syndrome, unspecified wrist M05.041 Felty's syndrome, right hand M05.042 Felty's syndrome, left hand M05.049 Felty's syndrome, unspecified hand M05.051 Felty's syndrome, right hip M05.052 Felty's syndrome, left hip M05.059 Felty's syndrome, unspecified hip M05.061 Felty's syndrome, right knee M05.062 Felty's syndrome, left knee M05.069 Felty's syndrome, unspecified knee M05.071 Felty's syndrome, right ankle and foot M05.072 Felty's syndrome, left ankle and foot M05.079 Felty's syndrome, unspecified ankle and foot M05.09 Felty's syndrome, multiple sites M05.20 Rheumatoid vasculitis with rheumatoid arthritis of unspecified site M05.211 Rheumatoid vasculitis with rheumatoid arthritis of right shoulder M05.212 Rheumatoid vasculitis with rheumatoid arthritis of left shoulder M05.219 Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder M05.221 Rheumatoid vasculitis with rheumatoid arthritis of right elbow M05.222 Rheumatoid vasculitis with rheumatoid arthritis of left elbow M05.229 Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow M05.231 Rheumatoid vasculitis with rheumatoid arthritis of right wrist M05.232 Rheumatoid vasculitis with rheumatoid arthritis of left wrist M05.239 Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist M05.241 Rheumatoid vasculitis with rheumatoid arthritis of right hand M05.242 Rheumatoid vasculitis with rheumatoid arthritis of left hand M05.249 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand M05.251 Rheumatoid vasculitis with rheumatoid arthritis of right hip M05.252 Rheumatoid vasculitis with rheumatoid arthritis of left hip M05.259 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip M05.261 Rheumatoid vasculitis with rheumatoid arthritis of right knee M05.262 Rheumatoid vasculitis with rheumatoid arthritis of left knee

Page 16: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.269 Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee M05.271 Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot M05.272 Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot M05.279 Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot M05.29 Rheumatoid vasculitis with rheumatoid arthritis of multiple sites M05.30 Rheumatoid heart disease with rheumatoid arthritis of unspecified site M05.311 Rheumatoid heart disease with rheumatoid arthritis of right shoulder M05.312 Rheumatoid heart disease with rheumatoid arthritis of left shoulder M05.319 Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder M05.321 Rheumatoid heart disease with rheumatoid arthritis of right elbow M05.322 Rheumatoid heart disease with rheumatoid arthritis of left elbow M05.329 Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow M05.331 Rheumatoid heart disease with rheumatoid arthritis of right wrist M05.332 Rheumatoid heart disease with rheumatoid arthritis of left wrist M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist M05.341 Rheumatoid heart disease with rheumatoid arthritis of right hand M05.342 Rheumatoid heart disease with rheumatoid arthritis of left hand M05.349 Rheumatoid heart disease with rheumatoid arthritis of unspecified hand M05.351 Rheumatoid heart disease with rheumatoid arthritis of right hip M05.352 Rheumatoid heart disease with rheumatoid arthritis of left hip M05.359 Rheumatoid heart disease with rheumatoid arthritis of unspecified hip M05.361 Rheumatoid heart disease with rheumatoid arthritis of right knee M05.362 Rheumatoid heart disease with rheumatoid arthritis of left knee M05.369 Rheumatoid heart disease with rheumatoid arthritis of unspecified knee M05.371 Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot M05.372 Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot M05.379 Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot M05.39 Rheumatoid heart disease with rheumatoid arthritis of multiple sites M05.40 Rheumatoid myopathy with rheumatoid arthritis of unspecified site M05.411 Rheumatoid myopathy with rheumatoid arthritis of right shoulder M05.412 Rheumatoid myopathy with rheumatoid arthritis of left shoulder M05.419 Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder M05.421 Rheumatoid myopathy with rheumatoid arthritis of right elbow M05.422 Rheumatoid myopathy with rheumatoid arthritis of left elbow M05.429 Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow M05.431 Rheumatoid myopathy with rheumatoid arthritis of right wrist M05.432 Rheumatoid myopathy with rheumatoid arthritis of left wrist M05.439 Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist M05.441 Rheumatoid myopathy with rheumatoid arthritis of right hand M05.442 Rheumatoid myopathy with rheumatoid arthritis of left hand M05.449 Rheumatoid myopathy with rheumatoid arthritis of unspecified hand M05.451 Rheumatoid myopathy with rheumatoid arthritis of right hip M05.452 Rheumatoid myopathy with rheumatoid arthritis of left hip M05.459 Rheumatoid myopathy with rheumatoid arthritis of unspecified hip M05.461 Rheumatoid myopathy with rheumatoid arthritis of right knee M05.462 Rheumatoid myopathy with rheumatoid arthritis of left knee M05.469 Rheumatoid myopathy with rheumatoid arthritis of unspecified knee M05.471 Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot M05.472 Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot M05.479 Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot M05.49 Rheumatoid myopathy with rheumatoid arthritis of multiple sites M05.50 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site M05.511 Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder M05.512 Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder M05.519 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder M05.521 Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow

Page 17: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.522 Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow M05.529 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow M05.531 Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist M05.532 Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist M05.539 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist M05.541 Rheumatoid polyneuropathy with rheumatoid arthritis of right hand M05.542 Rheumatoid polyneuropathy with rheumatoid arthritis of left hand M05.549 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand M05.551 Rheumatoid polyneuropathy with rheumatoid arthritis of right hip M05.552 Rheumatoid polyneuropathy with rheumatoid arthritis of left hip M05.559 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip M05.561 Rheumatoid polyneuropathy with rheumatoid arthritis of right knee M05.562 Rheumatoid polyneuropathy with rheumatoid arthritis of left knee M05.569 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee M05.571 Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot M05.572 Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot M05.579 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot M05.59 Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites M05.60 Rheumatoid arthritis of unspecified site with involvement of other organs and systems M05.611 Rheumatoid arthritis of right shoulder with involvement of other organs and systems M05.612 Rheumatoid arthritis of left shoulder with involvement of other organs and systems

M05.619 Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

M05.621 Rheumatoid arthritis of right elbow with involvement of other organs and systems M05.622 Rheumatoid arthritis of left elbow with involvement of other organs and systems

M05.629 Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems

M05.631 Rheumatoid arthritis of right wrist with involvement of other organs and systems M05.632 Rheumatoid arthritis of left wrist with involvement of other organs and systems M05.639 Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems M05.641 Rheumatoid arthritis of right hand with involvement of other organs and systems M05.642 Rheumatoid arthritis of left hand with involvement of other organs and systems M05.649 Rheumatoid arthritis of unspecified hand with involvement of other organs and systems M05.651 Rheumatoid arthritis of right hip with involvement of other organs and systems M05.652 Rheumatoid arthritis of left hip with involvement of other organs and systems M05.659 Rheumatoid arthritis of unspecified hip with involvement of other organs and systems M05.661 Rheumatoid arthritis of right knee with involvement of other organs and systems M05.662 Rheumatoid arthritis of left knee with involvement of other organs and systems M05.669 Rheumatoid arthritis of unspecified knee with involvement of other organs and systems

M05.671 Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems

M05.672 Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems

M05.679 Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems

M05.69 Rheumatoid arthritis of multiple sites with involvement of other organs and systems

M05.70 Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement

M05.711 Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement

M05.712 Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement

M05.719 Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement

M05.721 Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement

M05.722 Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems

Page 18: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

involvement

M05.729 Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement

M05.731 Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement

M05.732 Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement

M05.739 Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement

M05.741 Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement

M05.742 Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement

M05.749 Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement

M05.751 Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement

M05.752 Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement

M05.759 Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement

M05.761 Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement

M05.762 Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement

M05.769 Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement

M05.771 Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement

M05.772 Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement

M05.779 Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement

M05.79 Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement

M05.80 Other rheumatoid arthritis with rheumatoid factor of unspecified site M05.811 Other rheumatoid arthritis with rheumatoid factor of right shoulder M05.812 Other rheumatoid arthritis with rheumatoid factor of left shoulder M05.819 Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder M05.821 Other rheumatoid arthritis with rheumatoid factor of right elbow M05.822 Other rheumatoid arthritis with rheumatoid factor of left elbow M05.829 Other rheumatoid arthritis with rheumatoid factor of unspecified elbow M05.831 Other rheumatoid arthritis with rheumatoid factor of right wrist M05.832 Other rheumatoid arthritis with rheumatoid factor of left wrist M05.839 Other rheumatoid arthritis with rheumatoid factor of unspecified wrist M05.841 Other rheumatoid arthritis with rheumatoid factor of right hand M05.842 Other rheumatoid arthritis with rheumatoid factor of left hand M05.849 Other rheumatoid arthritis with rheumatoid factor of unspecified hand M05.851 Other rheumatoid arthritis with rheumatoid factor of right hip M05.852 Other rheumatoid arthritis with rheumatoid factor of left hip M05.859 Other rheumatoid arthritis with rheumatoid factor of unspecified hip M05.861 Other rheumatoid arthritis with rheumatoid factor of right knee M05.862 Other rheumatoid arthritis with rheumatoid factor of left knee M05.869 Other rheumatoid arthritis with rheumatoid factor of unspecified knee M05.871 Other rheumatoid arthritis with rheumatoid factor of right ankle and foot M05.872 Other rheumatoid arthritis with rheumatoid factor of left ankle and foot M05.879 Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot M05.89 Other rheumatoid arthritis with rheumatoid factor of multiple sites

Page 19: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.011 Rheumatoid arthritis without rheumatoid factor, right shoulder M06.012 Rheumatoid arthritis without rheumatoid factor, left shoulder M06.019 Rheumatoid arthritis without rheumatoid factor, unspecified shoulder M06.021 Rheumatoid arthritis without rheumatoid factor, right elbow M06.022 Rheumatoid arthritis without rheumatoid factor, left elbow M06.029 Rheumatoid arthritis without rheumatoid factor, unspecified elbow M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist M06.039 Rheumatoid arthritis without rheumatoid factor, unspecified wrist M06.041 Rheumatoid arthritis without rheumatoid factor, right hand M06.042 Rheumatoid arthritis without rheumatoid factor, left hand M06.049 Rheumatoid arthritis without rheumatoid factor, unspecified hand M06.051 Rheumatoid arthritis without rheumatoid factor, right hip M06.052 Rheumatoid arthritis without rheumatoid factor, left hip M06.059 Rheumatoid arthritis without rheumatoid factor, unspecified hip M06.061 Rheumatoid arthritis without rheumatoid factor, right knee M06.062 Rheumatoid arthritis without rheumatoid factor, left knee M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee M06.071 Rheumatoid arthritis without rheumatoid factor, right ankle and foot M06.072 Rheumatoid arthritis without rheumatoid factor, left ankle and foot M06.079 Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot M06.08 Rheumatoid arthritis without rheumatoid factor, vertebrae M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites M06.1 Adult-onset Still's disease M06.80 Other specified rheumatoid arthritis, unspecified site M06.811 Other specified rheumatoid arthritis, right shoulder M06.812 Other specified rheumatoid arthritis, left shoulder M06.819 Other specified rheumatoid arthritis, unspecified shoulder M06.821 Other specified rheumatoid arthritis, right elbow M06.822 Other specified rheumatoid arthritis, left elbow M06.829 Other specified rheumatoid arthritis, unspecified elbow M06.831 Other specified rheumatoid arthritis, right wrist M06.832 Other specified rheumatoid arthritis, left wrist M06.839 Other specified rheumatoid arthritis, unspecified wrist M06.841 Other specified rheumatoid arthritis, right hand M06.842 Other specified rheumatoid arthritis, left hand M06.849 Other specified rheumatoid arthritis, unspecified hand M06.851 Other specified rheumatoid arthritis, right hip M06.852 Other specified rheumatoid arthritis, left hip M06.859 Other specified rheumatoid arthritis, unspecified hip M06.861 Other specified rheumatoid arthritis, right knee M06.862 Other specified rheumatoid arthritis, left knee M06.869 Other specified rheumatoid arthritis, unspecified knee M06.871 Other specified rheumatoid arthritis, right ankle and foot M06.872 Other specified rheumatoid arthritis, left ankle and foot M06.879 Other specified rheumatoid arthritis, unspecified ankle and foot M06.88 Other specified rheumatoid arthritis, vertebrae M06.89 Other specified rheumatoid arthritis, multiple sites M06.9 Rheumatoid arthritis, unspecified M08.00 Unspecified juvenile rheumatoid arthritis of unspecified site M08.011 Unspecified juvenile rheumatoid arthritis, right shoulder M08.012 Unspecified juvenile rheumatoid arthritis, left shoulder M08.019 Unspecified juvenile rheumatoid arthritis, unspecified shoulder M08.021 Unspecified juvenile rheumatoid arthritis, right elbow

Page 20: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.022 Unspecified juvenile rheumatoid arthritis, left elbow M08.029 Unspecified juvenile rheumatoid arthritis, unspecified elbow M08.031 Unspecified juvenile rheumatoid arthritis, right wrist M08.032 Unspecified juvenile rheumatoid arthritis, left wrist M08.039 Unspecified juvenile rheumatoid arthritis, unspecified wrist M08.041 Unspecified juvenile rheumatoid arthritis, right hand M08.042 Unspecified juvenile rheumatoid arthritis, left hand M08.049 Unspecified juvenile rheumatoid arthritis, unspecified hand M08.051 Unspecified juvenile rheumatoid arthritis, right hip M08.052 Unspecified juvenile rheumatoid arthritis, left hip M08.059 Unspecified juvenile rheumatoid arthritis, unspecified hip M08.061 Unspecified juvenile rheumatoid arthritis, right knee M08.062 Unspecified juvenile rheumatoid arthritis, left knee M08.069 Unspecified juvenile rheumatoid arthritis, unspecified knee M08.071 Unspecified juvenile rheumatoid arthritis, right ankle and foot M08.072 Unspecified juvenile rheumatoid arthritis, left ankle and foot M08.079 Unspecified juvenile rheumatoid arthritis, unspecified ankle and foot M08.08 Unspecified juvenile rheumatoid arthritis, vertebrae M08.09 Unspecified juvenile rheumatoid arthritis, multiple sites M08.20 Juvenile rheumatoid arthritis with systemic onset, unspecified site M08.211 Juvenile rheumatoid arthritis with systemic onset, right shoulder M08.212 Juvenile rheumatoid arthritis with systemic onset, left shoulder M08.219 Juvenile rheumatoid arthritis with systemic onset, unspecified shoulder M08.221 Juvenile rheumatoid arthritis with systemic onset, right elbow M08.222 Juvenile rheumatoid arthritis with systemic onset, left elbow M08.229 Juvenile rheumatoid arthritis with systemic onset, unspecified elbow M08.231 Juvenile rheumatoid arthritis with systemic onset, right wrist M08.232 Juvenile rheumatoid arthritis with systemic onset, left wrist M08.239 Juvenile rheumatoid arthritis with systemic onset, unspecified wrist M08.241 Juvenile rheumatoid arthritis with systemic onset, right hand M08.242 Juvenile rheumatoid arthritis with systemic onset, left hand M08.249 Juvenile rheumatoid arthritis with systemic onset, unspecified hand M08.251 Juvenile rheumatoid arthritis with systemic onset, right hip M08.252 Juvenile rheumatoid arthritis with systemic onset, left hip M08.259 Juvenile rheumatoid arthritis with systemic onset, unspecified hip M08.261 Juvenile rheumatoid arthritis with systemic onset, right knee M08.262 Juvenile rheumatoid arthritis with systemic onset, left knee M08.269 Juvenile rheumatoid arthritis with systemic onset, unspecified knee M08.271 Juvenile rheumatoid arthritis with systemic onset, right ankle and foot M08.272 Juvenile rheumatoid arthritis with systemic onset, left ankle and foot M08.279 Juvenile rheumatoid arthritis with systemic onset, unspecified ankle and foot M08.28 Juvenile rheumatoid arthritis with systemic onset, vertebrae M08.29 Juvenile rheumatoid arthritis with systemic onset, multiple sites M08.3 Juvenile rheumatoid polyarthritis (seronegative) M08.40 Pauciarticular juvenile rheumatoid arthritis, unspecified site M08.411 Pauciarticular juvenile rheumatoid arthritis, right shoulder M08.412 Pauciarticular juvenile rheumatoid arthritis, left shoulder M08.419 Pauciarticular juvenile rheumatoid arthritis, unspecified shoulder M08.421 Pauciarticular juvenile rheumatoid arthritis, right elbow M08.422 Pauciarticular juvenile rheumatoid arthritis, left elbow M08.429 Pauciarticular juvenile rheumatoid arthritis, unspecified elbow M08.431 Pauciarticular juvenile rheumatoid arthritis, right wrist M08.432 Pauciarticular juvenile rheumatoid arthritis, left wrist M08.439 Pauciarticular juvenile rheumatoid arthritis, unspecified wrist M08.441 Pauciarticular juvenile rheumatoid arthritis, right hand M08.442 Pauciarticular juvenile rheumatoid arthritis, left hand

Page 21: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.449 Pauciarticular juvenile rheumatoid arthritis, unspecified hand M08.451 Pauciarticular juvenile rheumatoid arthritis, right hip M08.452 Pauciarticular juvenile rheumatoid arthritis, left hip M08.459 Pauciarticular juvenile rheumatoid arthritis, unspecified hip M08.461 Pauciarticular juvenile rheumatoid arthritis, right knee M08.462 Pauciarticular juvenile rheumatoid arthritis, left knee M08.469 Pauciarticular juvenile rheumatoid arthritis, unspecified knee M08.471 Pauciarticular juvenile rheumatoid arthritis, right ankle and foot M08.472 Pauciarticular juvenile rheumatoid arthritis, left ankle and foot M08.479 Pauciarticular juvenile rheumatoid arthritis, unspecified ankle and foot M08.48 Pauciarticular juvenile rheumatoid arthritis, vertebrae M08.80 Other juvenile arthritis, unspecified site M08.811 Other juvenile arthritis, right shoulder M08.812 Other juvenile arthritis, left shoulder M08.819 Other juvenile arthritis, unspecified shoulder M08.821 Other juvenile arthritis, right elbow M08.822 Other juvenile arthritis, left elbow M08.829 Other juvenile arthritis, unspecified elbow M08.831 Other juvenile arthritis, right wrist M08.832 Other juvenile arthritis, left wrist M08.839 Other juvenile arthritis, unspecified wrist M08.841 Other juvenile arthritis, right hand M08.842 Other juvenile arthritis, left hand M08.849 Other juvenile arthritis, unspecified hand M08.851 Other juvenile arthritis, right hip M08.852 Other juvenile arthritis, left hip M08.859 Other juvenile arthritis, unspecified hip M08.861 Other juvenile arthritis, right knee M08.862 Other juvenile arthritis, left knee M08.869 Other juvenile arthritis, unspecified knee M08.871 Other juvenile arthritis, right ankle and foot M08.872 Other juvenile arthritis, left ankle and foot M08.879 Other juvenile arthritis, unspecified ankle and foot M08.88 Other juvenile arthritis, other specified site M08.89 Other juvenile arthritis, multiple sites M08.90 Juvenile arthritis, unspecified, unspecified site M08.911 Juvenile arthritis, unspecified, right shoulder M08.912 Juvenile arthritis, unspecified, left shoulder M08.919 Juvenile arthritis, unspecified, unspecified shoulder M08.921 Juvenile arthritis, unspecified, right elbow M08.922 Juvenile arthritis, unspecified, left elbow M08.929 Juvenile arthritis, unspecified, unspecified elbow M08.931 Juvenile arthritis, unspecified, right wrist M08.932 Juvenile arthritis, unspecified, left wrist M08.939 Juvenile arthritis, unspecified, unspecified wrist M08.941 Juvenile arthritis, unspecified, right hand M08.942 Juvenile arthritis, unspecified, left hand M08.949 Juvenile arthritis, unspecified, unspecified hand M08.951 Juvenile arthritis, unspecified, right hip M08.952 Juvenile arthritis, unspecified, left hip M08.959 Juvenile arthritis, unspecified, unspecified hip M08.961 Juvenile arthritis, unspecified, right knee M08.962 Juvenile arthritis, unspecified, left knee M08.969 Juvenile arthritis, unspecified, unspecified knee M08.971 Juvenile arthritis, unspecified, right ankle and foot M08.972 Juvenile arthritis, unspecified, left ankle and foot

Page 22: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.979 Juvenile arthritis, unspecified, unspecified ankle and foot M08.98 Juvenile arthritis, unspecified, vertebrae M08.99 Juvenile arthritis, unspecified, multiple sites

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes: HCPCS codes: Code Description J0717 Injection, certolizumab pegol, 1 mg (Cimzia®)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description K50.00 Crohn's disease of small intestine without complications K50.011 Crohn's disease of small intestine with rectal bleeding K50.012 Crohn's disease of small intestine with intestinal obstruction K50.013 Crohn's disease of small intestine with fistula K50.014 Crohn's disease of small intestine with abscess K50.018 Crohn's disease of small intestine with other complication K50.019 Crohn's disease of small intestine with unspecified complications K50.10 Crohn's disease of large intestine without complications K50.111 Crohn's disease of large intestine with rectal bleeding K50.112 Crohn's disease of large intestine with intestinal obstruction K50.113 Crohn's disease of large intestine with fistula K50.114 Crohn's disease of large intestine with abscess K50.118 Crohn's disease of large intestine with other complication K50.119 Crohn's disease of large intestine with unspecified complications K50.80 Crohn's disease of both small and large intestine without complications K50.811 Crohn's disease of both small and large intestine with rectal bleeding K50.812 Crohn's disease of both small and large intestine with intestinal obstruction K50.813 Crohn's disease of both small and large intestine with fistula K50.814 Crohn's disease of both small and large intestine with abscess K50.818 Crohn's disease of both small and large intestine with other complication K50.819 Crohn's disease of both small and large intestine with unspecified complications K50.90 Crohn's disease, unspecified, without complications K50.911 Crohn's disease, unspecified, with rectal bleeding K50.912 Crohn's disease, unspecified, with intestinal obstruction K50.913 Crohn's disease, unspecified, with fistula K50.914 Crohn's disease, unspecified, with abscess K50.918 Crohn's disease, unspecified, with other complication K50.919 Crohn's disease, unspecified, with unspecified complications L40.50 Arthropathic psoriasis, unspecified L40.51 Distal interphalangeal psoriatic arthropathy L40.52 Psoriatic arthritis mutilans L40.59 Other psoriatic arthropathy M05.00 Felty's syndrome, unspecified site M05.011 Felty's syndrome, right shoulder M05.012 Felty's syndrome, left shoulder M05.019 Felty's syndrome, unspecified shoulder M05.021 Felty's syndrome, right elbow M05.022 Felty's syndrome, left elbow

Page 23: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.029 Felty's syndrome, unspecified elbow M05.031 Felty's syndrome, right wrist M05.032 Felty's syndrome, left wrist M05.039 Felty's syndrome, unspecified wrist M05.041 Felty's syndrome, right hand M05.042 Felty's syndrome, left hand M05.049 Felty's syndrome, unspecified hand M05.051 Felty's syndrome, right hip M05.052 Felty's syndrome, left hip M05.059 Felty's syndrome, unspecified hip M05.061 Felty's syndrome, right knee M05.062 Felty's syndrome, left knee M05.069 Felty's syndrome, unspecified knee M05.071 Felty's syndrome, right ankle and foot M05.072 Felty's syndrome, left ankle and foot M05.079 Felty's syndrome, unspecified ankle and foot M05.09 Felty's syndrome, multiple sites M05.20 Rheumatoid vasculitis with rheumatoid arthritis of unspecified site M05.211 Rheumatoid vasculitis with rheumatoid arthritis of right shoulder M05.212 Rheumatoid vasculitis with rheumatoid arthritis of left shoulder M05.219 Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder M05.221 Rheumatoid vasculitis with rheumatoid arthritis of right elbow M05.222 Rheumatoid vasculitis with rheumatoid arthritis of left elbow M05.229 Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow M05.231 Rheumatoid vasculitis with rheumatoid arthritis of right wrist M05.232 Rheumatoid vasculitis with rheumatoid arthritis of left wrist M05.239 Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist M05.241 Rheumatoid vasculitis with rheumatoid arthritis of right hand M05.242 Rheumatoid vasculitis with rheumatoid arthritis of left hand M05.249 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand M05.251 Rheumatoid vasculitis with rheumatoid arthritis of right hip M05.252 Rheumatoid vasculitis with rheumatoid arthritis of left hip M05.259 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip M05.261 Rheumatoid vasculitis with rheumatoid arthritis of right knee M05.262 Rheumatoid vasculitis with rheumatoid arthritis of left knee M05.269 Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee M05.271 Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot M05.272 Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot M05.279 Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot M05.29 Rheumatoid vasculitis with rheumatoid arthritis of multiple sites M05.30 Rheumatoid heart disease with rheumatoid arthritis of unspecified site M05.311 Rheumatoid heart disease with rheumatoid arthritis of right shoulder M05.312 Rheumatoid heart disease with rheumatoid arthritis of left shoulder M05.319 Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder M05.321 Rheumatoid heart disease with rheumatoid arthritis of right elbow M05.322 Rheumatoid heart disease with rheumatoid arthritis of left elbow M05.329 Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow M05.331 Rheumatoid heart disease with rheumatoid arthritis of right wrist M05.332 Rheumatoid heart disease with rheumatoid arthritis of left wrist M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist M05.341 Rheumatoid heart disease with rheumatoid arthritis of right hand M05.342 Rheumatoid heart disease with rheumatoid arthritis of left hand M05.349 Rheumatoid heart disease with rheumatoid arthritis of unspecified hand M05.351 Rheumatoid heart disease with rheumatoid arthritis of right hip M05.352 Rheumatoid heart disease with rheumatoid arthritis of left hip M05.359 Rheumatoid heart disease with rheumatoid arthritis of unspecified hip

Page 24: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.361 Rheumatoid heart disease with rheumatoid arthritis of right knee M05.362 Rheumatoid heart disease with rheumatoid arthritis of left knee M05.369 Rheumatoid heart disease with rheumatoid arthritis of unspecified knee M05.371 Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot M05.372 Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot M05.379 Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot M05.39 Rheumatoid heart disease with rheumatoid arthritis of multiple sites M05.40 Rheumatoid myopathy with rheumatoid arthritis of unspecified site M05.411 Rheumatoid myopathy with rheumatoid arthritis of right shoulder M05.412 Rheumatoid myopathy with rheumatoid arthritis of left shoulder M05.419 Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder M05.421 Rheumatoid myopathy with rheumatoid arthritis of right elbow M05.422 Rheumatoid myopathy with rheumatoid arthritis of left elbow M05.429 Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow M05.431 Rheumatoid myopathy with rheumatoid arthritis of right wrist M05.432 Rheumatoid myopathy with rheumatoid arthritis of left wrist M05.439 Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist M05.441 Rheumatoid myopathy with rheumatoid arthritis of right hand M05.442 Rheumatoid myopathy with rheumatoid arthritis of left hand M05.449 Rheumatoid myopathy with rheumatoid arthritis of unspecified hand M05.451 Rheumatoid myopathy with rheumatoid arthritis of right hip M05.452 Rheumatoid myopathy with rheumatoid arthritis of left hip M05.459 Rheumatoid myopathy with rheumatoid arthritis of unspecified hip M05.461 Rheumatoid myopathy with rheumatoid arthritis of right knee M05.462 Rheumatoid myopathy with rheumatoid arthritis of left knee M05.469 Rheumatoid myopathy with rheumatoid arthritis of unspecified knee M05.471 Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot M05.472 Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot M05.479 Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot M05.49 Rheumatoid myopathy with rheumatoid arthritis of multiple sites M05.50 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site M05.511 Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder M05.512 Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder M05.519 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder M05.521 Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow M05.522 Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow M05.529 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow M05.531 Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist M05.532 Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist M05.539 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist M05.541 Rheumatoid polyneuropathy with rheumatoid arthritis of right hand M05.542 Rheumatoid polyneuropathy with rheumatoid arthritis of left hand M05.549 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand M05.551 Rheumatoid polyneuropathy with rheumatoid arthritis of right hip M05.552 Rheumatoid polyneuropathy with rheumatoid arthritis of left hip M05.559 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip M05.561 Rheumatoid polyneuropathy with rheumatoid arthritis of right knee M05.562 Rheumatoid polyneuropathy with rheumatoid arthritis of left knee M05.569 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee M05.571 Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot M05.572 Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot M05.579 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot M05.59 Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites M05.60 Rheumatoid arthritis of unspecified site with involvement of other organs and systems M05.611 Rheumatoid arthritis of right shoulder with involvement of other organs and systems M05.612 Rheumatoid arthritis of left shoulder with involvement of other organs and systems

Page 25: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.619 Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

M05.621 Rheumatoid arthritis of right elbow with involvement of other organs and systems M05.622 Rheumatoid arthritis of left elbow with involvement of other organs and systems

M05.629 Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems

M05.631 Rheumatoid arthritis of right wrist with involvement of other organs and systems M05.632 Rheumatoid arthritis of left wrist with involvement of other organs and systems M05.639 Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems M05.641 Rheumatoid arthritis of right hand with involvement of other organs and systems M05.642 Rheumatoid arthritis of left hand with involvement of other organs and systems M05.649 Rheumatoid arthritis of unspecified hand with involvement of other organs and systems M05.651 Rheumatoid arthritis of right hip with involvement of other organs and systems M05.652 Rheumatoid arthritis of left hip with involvement of other organs and systems M05.659 Rheumatoid arthritis of unspecified hip with involvement of other organs and systems M05.661 Rheumatoid arthritis of right knee with involvement of other organs and systems M05.662 Rheumatoid arthritis of left knee with involvement of other organs and systems M05.669 Rheumatoid arthritis of unspecified knee with involvement of other organs and systems

M05.671 Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems

M05.672 Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems

M05.679 Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems

M05.69 Rheumatoid arthritis of multiple sites with involvement of other organs and systems

M05.70 Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement

M05.711 Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement

M05.712 Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement

M05.719 Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement

M05.721 Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement

M05.722 Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement

M05.729 Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement

M05.731 Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement

M05.732 Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement

M05.739 Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement

M05.741 Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement

M05.742 Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement

M05.749 Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement

M05.751 Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement

M05.752 Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement

M05.759 Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement

M05.761 Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement

Page 26: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.762 Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement

M05.769 Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement

M05.771 Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement

M05.772 Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement

M05.779 Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement

M05.79 Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement

M05.80 Other rheumatoid arthritis with rheumatoid factor of unspecified site M05.811 Other rheumatoid arthritis with rheumatoid factor of right shoulder M05.812 Other rheumatoid arthritis with rheumatoid factor of left shoulder M05.819 Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder M05.821 Other rheumatoid arthritis with rheumatoid factor of right elbow M05.822 Other rheumatoid arthritis with rheumatoid factor of left elbow M05.829 Other rheumatoid arthritis with rheumatoid factor of unspecified elbow M05.831 Other rheumatoid arthritis with rheumatoid factor of right wrist M05.832 Other rheumatoid arthritis with rheumatoid factor of left wrist M05.839 Other rheumatoid arthritis with rheumatoid factor of unspecified wrist M05.841 Other rheumatoid arthritis with rheumatoid factor of right hand M05.842 Other rheumatoid arthritis with rheumatoid factor of left hand M05.849 Other rheumatoid arthritis with rheumatoid factor of unspecified hand M05.851 Other rheumatoid arthritis with rheumatoid factor of right hip M05.852 Other rheumatoid arthritis with rheumatoid factor of left hip M05.859 Other rheumatoid arthritis with rheumatoid factor of unspecified hip M05.861 Other rheumatoid arthritis with rheumatoid factor of right knee M05.862 Other rheumatoid arthritis with rheumatoid factor of left knee M05.869 Other rheumatoid arthritis with rheumatoid factor of unspecified knee M05.871 Other rheumatoid arthritis with rheumatoid factor of right ankle and foot M05.872 Other rheumatoid arthritis with rheumatoid factor of left ankle and foot M05.879 Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot M05.89 Other rheumatoid arthritis with rheumatoid factor of multiple sites M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.011 Rheumatoid arthritis without rheumatoid factor, right shoulder M06.012 Rheumatoid arthritis without rheumatoid factor, left shoulder M06.019 Rheumatoid arthritis without rheumatoid factor, unspecified shoulder M06.021 Rheumatoid arthritis without rheumatoid factor, right elbow M06.022 Rheumatoid arthritis without rheumatoid factor, left elbow M06.029 Rheumatoid arthritis without rheumatoid factor, unspecified elbow M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist M06.039 Rheumatoid arthritis without rheumatoid factor, unspecified wrist M06.041 Rheumatoid arthritis without rheumatoid factor, right hand M06.042 Rheumatoid arthritis without rheumatoid factor, left hand M06.049 Rheumatoid arthritis without rheumatoid factor, unspecified hand M06.051 Rheumatoid arthritis without rheumatoid factor, right hip M06.052 Rheumatoid arthritis without rheumatoid factor, left hip M06.059 Rheumatoid arthritis without rheumatoid factor, unspecified hip M06.061 Rheumatoid arthritis without rheumatoid factor, right knee M06.062 Rheumatoid arthritis without rheumatoid factor, left knee M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee M06.071 Rheumatoid arthritis without rheumatoid factor, right ankle and foot M06.072 Rheumatoid arthritis without rheumatoid factor, left ankle and foot

Page 27: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M06.079 Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot M06.08 Rheumatoid arthritis without rheumatoid factor, vertebrae M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites M06.1 Adult-onset Still's disease M06.80 Other specified rheumatoid arthritis, unspecified site M06.811 Other specified rheumatoid arthritis, right shoulder M06.812 Other specified rheumatoid arthritis, left shoulder M06.819 Other specified rheumatoid arthritis, unspecified shoulder M06.821 Other specified rheumatoid arthritis, right elbow M06.822 Other specified rheumatoid arthritis, left elbow M06.829 Other specified rheumatoid arthritis, unspecified elbow M06.831 Other specified rheumatoid arthritis, right wrist M06.832 Other specified rheumatoid arthritis, left wrist M06.839 Other specified rheumatoid arthritis, unspecified wrist M06.841 Other specified rheumatoid arthritis, right hand M06.842 Other specified rheumatoid arthritis, left hand M06.849 Other specified rheumatoid arthritis, unspecified hand M06.851 Other specified rheumatoid arthritis, right hip M06.852 Other specified rheumatoid arthritis, left hip M06.859 Other specified rheumatoid arthritis, unspecified hip M06.861 Other specified rheumatoid arthritis, right knee M06.862 Other specified rheumatoid arthritis, left knee M06.869 Other specified rheumatoid arthritis, unspecified knee M06.871 Other specified rheumatoid arthritis, right ankle and foot M06.872 Other specified rheumatoid arthritis, left ankle and foot M06.879 Other specified rheumatoid arthritis, unspecified ankle and foot M06.88 Other specified rheumatoid arthritis, vertebrae M06.89 Other specified rheumatoid arthritis, multiple sites M06.9 Rheumatoid arthritis, unspecified M45.0 Ankylosing spondylitis of multiple sites in spine M45.1 Ankylosing spondylitis of occipito-atlanto-axial region M45.2 Ankylosing spondylitis of cervical region M45.3 Ankylosing spondylitis of cervicothoracic region M45.4 Ankylosing spondylitis of thoracic region M45.5 Ankylosing spondylitis of thoracolumbar region M45.6 Ankylosing spondylitis lumbar region M45.7 Ankylosing spondylitis of lumbosacral region M45.8 Ankylosing spondylitis sacral and sacrococcygeal region M45.9 Ankylosing spondylitis of unspecified sites in spine

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes HCPCS codes: Code Description J1438 Injection, etanercept, 25 mg (Enbrel®)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description L40.0 Psoriasis vulgaris L40.50 Arthropathic psoriasis, unspecified

Page 28: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

L40.51 Distal interphalangeal psoriatic arthropathy L40.52 Psoriatic arthritis mutilans L40.59 Other psoriatic arthropathy M05.00 Felty's syndrome, unspecified site M05.011 Felty's syndrome, right shoulder M05.012 Felty's syndrome, left shoulder M05.019 Felty's syndrome, unspecified shoulder M05.021 Felty's syndrome, right elbow M05.022 Felty's syndrome, left elbow M05.029 Felty's syndrome, unspecified elbow M05.031 Felty's syndrome, right wrist M05.032 Felty's syndrome, left wrist M05.039 Felty's syndrome, unspecified wrist M05.041 Felty's syndrome, right hand M05.042 Felty's syndrome, left hand M05.049 Felty's syndrome, unspecified hand M05.051 Felty's syndrome, right hip M05.052 Felty's syndrome, left hip M05.059 Felty's syndrome, unspecified hip M05.061 Felty's syndrome, right knee M05.062 Felty's syndrome, left knee M05.069 Felty's syndrome, unspecified knee M05.071 Felty's syndrome, right ankle and foot M05.072 Felty's syndrome, left ankle and foot M05.079 Felty's syndrome, unspecified ankle and foot M05.09 Felty's syndrome, multiple sites M05.20 Rheumatoid vasculitis with rheumatoid arthritis of unspecified site M05.211 Rheumatoid vasculitis with rheumatoid arthritis of right shoulder M05.212 Rheumatoid vasculitis with rheumatoid arthritis of left shoulder M05.219 Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder M05.221 Rheumatoid vasculitis with rheumatoid arthritis of right elbow M05.222 Rheumatoid vasculitis with rheumatoid arthritis of left elbow M05.229 Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow M05.231 Rheumatoid vasculitis with rheumatoid arthritis of right wrist M05.232 Rheumatoid vasculitis with rheumatoid arthritis of left wrist M05.239 Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist M05.241 Rheumatoid vasculitis with rheumatoid arthritis of right hand M05.242 Rheumatoid vasculitis with rheumatoid arthritis of left hand M05.249 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand M05.251 Rheumatoid vasculitis with rheumatoid arthritis of right hip M05.252 Rheumatoid vasculitis with rheumatoid arthritis of left hip M05.259 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip M05.261 Rheumatoid vasculitis with rheumatoid arthritis of right knee M05.262 Rheumatoid vasculitis with rheumatoid arthritis of left knee M05.269 Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee M05.271 Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot M05.272 Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot M05.279 Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot M05.29 Rheumatoid vasculitis with rheumatoid arthritis of multiple sites M05.30 Rheumatoid heart disease with rheumatoid arthritis of unspecified site M05.311 Rheumatoid heart disease with rheumatoid arthritis of right shoulder M05.312 Rheumatoid heart disease with rheumatoid arthritis of left shoulder M05.319 Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder M05.321 Rheumatoid heart disease with rheumatoid arthritis of right elbow M05.322 Rheumatoid heart disease with rheumatoid arthritis of left elbow M05.329 Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow

Page 29: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.331 Rheumatoid heart disease with rheumatoid arthritis of right wrist M05.332 Rheumatoid heart disease with rheumatoid arthritis of left wrist M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist M05.341 Rheumatoid heart disease with rheumatoid arthritis of right hand M05.342 Rheumatoid heart disease with rheumatoid arthritis of left hand M05.349 Rheumatoid heart disease with rheumatoid arthritis of unspecified hand M05.351 Rheumatoid heart disease with rheumatoid arthritis of right hip M05.352 Rheumatoid heart disease with rheumatoid arthritis of left hip M05.359 Rheumatoid heart disease with rheumatoid arthritis of unspecified hip M05.361 Rheumatoid heart disease with rheumatoid arthritis of right knee M05.362 Rheumatoid heart disease with rheumatoid arthritis of left knee M05.369 Rheumatoid heart disease with rheumatoid arthritis of unspecified knee M05.371 Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot M05.372 Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot M05.379 Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot M05.39 Rheumatoid heart disease with rheumatoid arthritis of multiple sites M05.40 Rheumatoid myopathy with rheumatoid arthritis of unspecified site M05.411 Rheumatoid myopathy with rheumatoid arthritis of right shoulder M05.412 Rheumatoid myopathy with rheumatoid arthritis of left shoulder M05.419 Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder M05.421 Rheumatoid myopathy with rheumatoid arthritis of right elbow M05.422 Rheumatoid myopathy with rheumatoid arthritis of left elbow M05.429 Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow M05.431 Rheumatoid myopathy with rheumatoid arthritis of right wrist M05.432 Rheumatoid myopathy with rheumatoid arthritis of left wrist M05.439 Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist M05.441 Rheumatoid myopathy with rheumatoid arthritis of right hand M05.442 Rheumatoid myopathy with rheumatoid arthritis of left hand M05.449 Rheumatoid myopathy with rheumatoid arthritis of unspecified hand M05.451 Rheumatoid myopathy with rheumatoid arthritis of right hip M05.452 Rheumatoid myopathy with rheumatoid arthritis of left hip M05.459 Rheumatoid myopathy with rheumatoid arthritis of unspecified hip M05.461 Rheumatoid myopathy with rheumatoid arthritis of right knee M05.462 Rheumatoid myopathy with rheumatoid arthritis of left knee M05.469 Rheumatoid myopathy with rheumatoid arthritis of unspecified knee M05.471 Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot M05.472 Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot M05.479 Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot M05.49 Rheumatoid myopathy with rheumatoid arthritis of multiple sites M05.50 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site M05.511 Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder M05.512 Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder M05.519 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder M05.521 Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow M05.522 Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow M05.529 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow M05.531 Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist M05.532 Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist M05.539 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist M05.541 Rheumatoid polyneuropathy with rheumatoid arthritis of right hand M05.542 Rheumatoid polyneuropathy with rheumatoid arthritis of left hand M05.549 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand M05.551 Rheumatoid polyneuropathy with rheumatoid arthritis of right hip M05.552 Rheumatoid polyneuropathy with rheumatoid arthritis of left hip M05.559 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip M05.561 Rheumatoid polyneuropathy with rheumatoid arthritis of right knee

Page 30: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.562 Rheumatoid polyneuropathy with rheumatoid arthritis of left knee M05.569 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee M05.571 Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot M05.572 Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot M05.579 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot M05.59 Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites M05.60 Rheumatoid arthritis of unspecified site with involvement of other organs and systems M05.611 Rheumatoid arthritis of right shoulder with involvement of other organs and systems M05.612 Rheumatoid arthritis of left shoulder with involvement of other organs and systems

M05.619 Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

M05.621 Rheumatoid arthritis of right elbow with involvement of other organs and systems M05.622 Rheumatoid arthritis of left elbow with involvement of other organs and systems

M05.629 Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems

M05.631 Rheumatoid arthritis of right wrist with involvement of other organs and systems M05.632 Rheumatoid arthritis of left wrist with involvement of other organs and systems M05.639 Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems M05.641 Rheumatoid arthritis of right hand with involvement of other organs and systems M05.642 Rheumatoid arthritis of left hand with involvement of other organs and systems M05.649 Rheumatoid arthritis of unspecified hand with involvement of other organs and systems M05.651 Rheumatoid arthritis of right hip with involvement of other organs and systems M05.652 Rheumatoid arthritis of left hip with involvement of other organs and systems M05.659 Rheumatoid arthritis of unspecified hip with involvement of other organs and systems M05.661 Rheumatoid arthritis of right knee with involvement of other organs and systems M05.662 Rheumatoid arthritis of left knee with involvement of other organs and systems M05.669 Rheumatoid arthritis of unspecified knee with involvement of other organs and systems

M05.671 Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems

M05.672 Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems

M05.679 Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems

M05.69 Rheumatoid arthritis of multiple sites with involvement of other organs and systems

M05.70 Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement

M05.711 Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement

M05.712 Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement

M05.719 Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement

M05.721 Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement

M05.722 Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement

M05.729 Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement

M05.731 Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement

M05.732 Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement

M05.739 Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement

M05.741 Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement

M05.742 Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement

Page 31: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.749 Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement

M05.751 Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement

M05.752 Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement

M05.759 Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement

M05.761 Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement

M05.762 Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement

M05.769 Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement

M05.771 Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement

M05.772 Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement

M05.779 Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement

M05.79 Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement

M05.80 Other rheumatoid arthritis with rheumatoid factor of unspecified site M05.811 Other rheumatoid arthritis with rheumatoid factor of right shoulder M05.812 Other rheumatoid arthritis with rheumatoid factor of left shoulder M05.819 Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder M05.821 Other rheumatoid arthritis with rheumatoid factor of right elbow M05.822 Other rheumatoid arthritis with rheumatoid factor of left elbow M05.829 Other rheumatoid arthritis with rheumatoid factor of unspecified elbow M05.831 Other rheumatoid arthritis with rheumatoid factor of right wrist M05.832 Other rheumatoid arthritis with rheumatoid factor of left wrist M05.839 Other rheumatoid arthritis with rheumatoid factor of unspecified wrist M05.841 Other rheumatoid arthritis with rheumatoid factor of right hand M05.842 Other rheumatoid arthritis with rheumatoid factor of left hand M05.849 Other rheumatoid arthritis with rheumatoid factor of unspecified hand M05.851 Other rheumatoid arthritis with rheumatoid factor of right hip M05.852 Other rheumatoid arthritis with rheumatoid factor of left hip M05.859 Other rheumatoid arthritis with rheumatoid factor of unspecified hip M05.861 Other rheumatoid arthritis with rheumatoid factor of right knee M05.862 Other rheumatoid arthritis with rheumatoid factor of left knee M05.869 Other rheumatoid arthritis with rheumatoid factor of unspecified knee M05.871 Other rheumatoid arthritis with rheumatoid factor of right ankle and foot M05.872 Other rheumatoid arthritis with rheumatoid factor of left ankle and foot M05.879 Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot M05.89 Other rheumatoid arthritis with rheumatoid factor of multiple sites M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.011 Rheumatoid arthritis without rheumatoid factor, right shoulder M06.012 Rheumatoid arthritis without rheumatoid factor, left shoulder M06.019 Rheumatoid arthritis without rheumatoid factor, unspecified shoulder M06.021 Rheumatoid arthritis without rheumatoid factor, right elbow M06.022 Rheumatoid arthritis without rheumatoid factor, left elbow M06.029 Rheumatoid arthritis without rheumatoid factor, unspecified elbow M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist M06.039 Rheumatoid arthritis without rheumatoid factor, unspecified wrist M06.041 Rheumatoid arthritis without rheumatoid factor, right hand

Page 32: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M06.042 Rheumatoid arthritis without rheumatoid factor, left hand M06.049 Rheumatoid arthritis without rheumatoid factor, unspecified hand M06.051 Rheumatoid arthritis without rheumatoid factor, right hip M06.052 Rheumatoid arthritis without rheumatoid factor, left hip M06.059 Rheumatoid arthritis without rheumatoid factor, unspecified hip M06.061 Rheumatoid arthritis without rheumatoid factor, right knee M06.062 Rheumatoid arthritis without rheumatoid factor, left knee M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee M06.071 Rheumatoid arthritis without rheumatoid factor, right ankle and foot M06.072 Rheumatoid arthritis without rheumatoid factor, left ankle and foot M06.079 Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot M06.08 Rheumatoid arthritis without rheumatoid factor, vertebrae M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites M06.1 Adult-onset Still's disease M06.80 Other specified rheumatoid arthritis, unspecified site M06.811 Other specified rheumatoid arthritis, right shoulder M06.812 Other specified rheumatoid arthritis, left shoulder M06.819 Other specified rheumatoid arthritis, unspecified shoulder M06.821 Other specified rheumatoid arthritis, right elbow M06.822 Other specified rheumatoid arthritis, left elbow M06.829 Other specified rheumatoid arthritis, unspecified elbow M06.831 Other specified rheumatoid arthritis, right wrist M06.832 Other specified rheumatoid arthritis, left wrist M06.839 Other specified rheumatoid arthritis, unspecified wrist M06.841 Other specified rheumatoid arthritis, right hand M06.842 Other specified rheumatoid arthritis, left hand M06.849 Other specified rheumatoid arthritis, unspecified hand M06.851 Other specified rheumatoid arthritis, right hip M06.852 Other specified rheumatoid arthritis, left hip M06.859 Other specified rheumatoid arthritis, unspecified hip M06.861 Other specified rheumatoid arthritis, right knee M06.862 Other specified rheumatoid arthritis, left knee M06.869 Other specified rheumatoid arthritis, unspecified knee M06.871 Other specified rheumatoid arthritis, right ankle and foot M06.872 Other specified rheumatoid arthritis, left ankle and foot M06.879 Other specified rheumatoid arthritis, unspecified ankle and foot M06.88 Other specified rheumatoid arthritis, vertebrae M06.89 Other specified rheumatoid arthritis, multiple sites M06.9 Rheumatoid arthritis, unspecified M08.00 Unspecified juvenile rheumatoid arthritis of unspecified site M08.011 Unspecified juvenile rheumatoid arthritis, right shoulder M08.012 Unspecified juvenile rheumatoid arthritis, left shoulder M08.019 Unspecified juvenile rheumatoid arthritis, unspecified shoulder M08.021 Unspecified juvenile rheumatoid arthritis, right elbow M08.022 Unspecified juvenile rheumatoid arthritis, left elbow M08.029 Unspecified juvenile rheumatoid arthritis, unspecified elbow M08.031 Unspecified juvenile rheumatoid arthritis, right wrist M08.032 Unspecified juvenile rheumatoid arthritis, left wrist M08.039 Unspecified juvenile rheumatoid arthritis, unspecified wrist M08.041 Unspecified juvenile rheumatoid arthritis, right hand M08.042 Unspecified juvenile rheumatoid arthritis, left hand M08.049 Unspecified juvenile rheumatoid arthritis, unspecified hand M08.051 Unspecified juvenile rheumatoid arthritis, right hip M08.052 Unspecified juvenile rheumatoid arthritis, left hip M08.059 Unspecified juvenile rheumatoid arthritis, unspecified hip M08.061 Unspecified juvenile rheumatoid arthritis, right knee

Page 33: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.062 Unspecified juvenile rheumatoid arthritis, left knee M08.069 Unspecified juvenile rheumatoid arthritis, unspecified knee M08.071 Unspecified juvenile rheumatoid arthritis, right ankle and foot M08.072 Unspecified juvenile rheumatoid arthritis, left ankle and foot M08.079 Unspecified juvenile rheumatoid arthritis, unspecified ankle and foot M08.08 Unspecified juvenile rheumatoid arthritis, vertebrae M08.09 Unspecified juvenile rheumatoid arthritis, multiple sites M08.20 Juvenile rheumatoid arthritis with systemic onset, unspecified site M08.211 Juvenile rheumatoid arthritis with systemic onset, right shoulder M08.212 Juvenile rheumatoid arthritis with systemic onset, left shoulder M08.219 Juvenile rheumatoid arthritis with systemic onset, unspecified shoulder M08.221 Juvenile rheumatoid arthritis with systemic onset, right elbow M08.222 Juvenile rheumatoid arthritis with systemic onset, left elbow M08.229 Juvenile rheumatoid arthritis with systemic onset, unspecified elbow M08.231 Juvenile rheumatoid arthritis with systemic onset, right wrist M08.232 Juvenile rheumatoid arthritis with systemic onset, left wrist M08.239 Juvenile rheumatoid arthritis with systemic onset, unspecified wrist M08.241 Juvenile rheumatoid arthritis with systemic onset, right hand M08.242 Juvenile rheumatoid arthritis with systemic onset, left hand M08.249 Juvenile rheumatoid arthritis with systemic onset, unspecified hand M08.251 Juvenile rheumatoid arthritis with systemic onset, right hip M08.252 Juvenile rheumatoid arthritis with systemic onset, left hip M08.259 Juvenile rheumatoid arthritis with systemic onset, unspecified hip M08.261 Juvenile rheumatoid arthritis with systemic onset, right knee M08.262 Juvenile rheumatoid arthritis with systemic onset, left knee M08.269 Juvenile rheumatoid arthritis with systemic onset, unspecified knee M08.271 Juvenile rheumatoid arthritis with systemic onset, right ankle and foot M08.272 Juvenile rheumatoid arthritis with systemic onset, left ankle and foot M08.279 Juvenile rheumatoid arthritis with systemic onset, unspecified ankle and foot M08.28 Juvenile rheumatoid arthritis with systemic onset, vertebrae M08.29 Juvenile rheumatoid arthritis with systemic onset, multiple sites M08.3 Juvenile rheumatoid polyarthritis (seronegative) M08.80 Other juvenile arthritis, unspecified site M08.811 Other juvenile arthritis, right shoulder M08.812 Other juvenile arthritis, left shoulder M08.819 Other juvenile arthritis, unspecified shoulder M08.821 Other juvenile arthritis, right elbow M08.822 Other juvenile arthritis, left elbow M08.829 Other juvenile arthritis, unspecified elbow M08.831 Other juvenile arthritis, right wrist M08.832 Other juvenile arthritis, left wrist M08.839 Other juvenile arthritis, unspecified wrist M08.841 Other juvenile arthritis, right hand M08.842 Other juvenile arthritis, left hand M08.849 Other juvenile arthritis, unspecified hand M08.851 Other juvenile arthritis, right hip M08.852 Other juvenile arthritis, left hip M08.859 Other juvenile arthritis, unspecified hip M08.861 Other juvenile arthritis, right knee M08.862 Other juvenile arthritis, left knee M08.869 Other juvenile arthritis, unspecified knee M08.871 Other juvenile arthritis, right ankle and foot M08.872 Other juvenile arthritis, left ankle and foot M08.879 Other juvenile arthritis, unspecified ankle and foot M08.88 Other juvenile arthritis, other specified site M08.89 Other juvenile arthritis, multiple sites

Page 34: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.90 Juvenile arthritis, unspecified, unspecified site M08.911 Juvenile arthritis, unspecified, right shoulder M08.912 Juvenile arthritis, unspecified, left shoulder M08.919 Juvenile arthritis, unspecified, unspecified shoulder M08.921 Juvenile arthritis, unspecified, right elbow M08.922 Juvenile arthritis, unspecified, left elbow M08.929 Juvenile arthritis, unspecified, unspecified elbow M08.931 Juvenile arthritis, unspecified, right wrist M08.932 Juvenile arthritis, unspecified, left wrist M08.939 Juvenile arthritis, unspecified, unspecified wrist M08.941 Juvenile arthritis, unspecified, right hand M08.942 Juvenile arthritis, unspecified, left hand M08.949 Juvenile arthritis, unspecified, unspecified hand M08.951 Juvenile arthritis, unspecified, right hip M08.952 Juvenile arthritis, unspecified, left hip M08.959 Juvenile arthritis, unspecified, unspecified hip M08.961 Juvenile arthritis, unspecified, right knee M08.962 Juvenile arthritis, unspecified, left knee M08.969 Juvenile arthritis, unspecified, unspecified knee M08.971 Juvenile arthritis, unspecified, right ankle and foot M08.972 Juvenile arthritis, unspecified, left ankle and foot M08.979 Juvenile arthritis, unspecified, unspecified ankle and foot M08.98 Juvenile arthritis, unspecified, vertebrae M08.99 Juvenile arthritis, unspecified, multiple sites M45.0 Ankylosing spondylitis of multiple sites in spine M45.1 Ankylosing spondylitis of occipito-atlanto-axial region M45.2 Ankylosing spondylitis of cervical region M45.3 Ankylosing spondylitis of cervicothoracic region M45.4 Ankylosing spondylitis of thoracic region M45.5 Ankylosing spondylitis of thoracolumbar region M45.6 Ankylosing spondylitis lumbar region M45.7 Ankylosing spondylitis of lumbosacral region M45.8 Ankylosing spondylitis sacral and sacrococcygeal region M45.9 Ankylosing spondylitis of unspecified sites in spine

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity: HCPCS Code HCPCS codes: Code Description J3380 Injection, vedolizumab, 1 mg (Entyvio®)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description K50.00 Crohn's disease of small intestine without complications K50.011 Crohn's disease of small intestine with rectal bleeding K50.012 Crohn's disease of small intestine with intestinal obstruction K50.013 Crohn's disease of small intestine with fistula K50.014 Crohn's disease of small intestine with abscess K50.018 Crohn's disease of small intestine with other complication

Page 35: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

K50.019 Crohn's disease of small intestine with unspecified complications K50.10 Crohn's disease of large intestine without complications K50.111 Crohn's disease of large intestine with rectal bleeding K50.112 Crohn's disease of large intestine with intestinal obstruction K50.113 Crohn's disease of large intestine with fistula K50.114 Crohn's disease of large intestine with abscess K50.118 Crohn's disease of large intestine with other complication K50.119 Crohn's disease of large intestine with unspecified complications K50.80 Crohn's disease of both small and large intestine without complications K50.811 Crohn's disease of both small and large intestine with rectal bleeding K50.812 Crohn's disease of both small and large intestine with intestinal obstruction K50.813 Crohn's disease of both small and large intestine with fistula K50.814 Crohn's disease of both small and large intestine with abscess K50.818 Crohn's disease of both small and large intestine with other complication K50.819 Crohn's disease of both small and large intestine with unspecified complications K50.90 Crohn's disease, unspecified, without complications K50.911 Crohn's disease, unspecified, with rectal bleeding K50.912 Crohn's disease, unspecified, with intestinal obstruction K50.913 Crohn's disease, unspecified, with fistula K50.914 Crohn's disease, unspecified, with abscess K50.918 Crohn's disease, unspecified, with other complication K50.919 Crohn's disease, unspecified, with unspecified complications K51.00 Ulcerative (Chronic) Pancolitis Without Complications K51.011 Ulcerative (Chronic) Pancolitis With Rectal Bleeding K51.012 Ulcerative (Chronic) Pancolitis With Intestinal Obstruction K51.013 Ulcerative (Chronic) Pancolitis With Fistula K51.014 Ulcerative (Chronic) Pancolitis With Abscess K51.018 Ulcerative (Chronic) Pancolitis With Other Complication K51.019 Ulcerative (Chronic) Pancolitis With Unspecified Complications K51.20 Ulcerative (Chronic) Proctitis Without Complications K51.211 Ulcerative (Chronic) Proctitis With Rectal Bleeding K51.212 Ulcerative (Chronic) Proctitis With Intestinal Obstruction K51.213 Ulcerative (Chronic) Proctitis With Fistula K51.214 Ulcerative (Chronic) Proctitis With Abscess K51.218 Ulcerative (Chronic) Proctitis With Other Complication K51.219 Ulcerative (Chronic) Proctitis With Unspecified Complications K51.30 Ulcerative (Chronic) Rectosigmoiditis Without Complications K51.311 Ulcerative (Chronic) Rectosigmoiditis With Rectal Bleeding K51.312 Ulcerative (Chronic) Rectosigmoiditis With Intestinal Obstruction K51.313 Ulcerative (Chronic) Rectosigmoiditis With Fistula K51.314 Ulcerative (Chronic) Rectosigmoiditis With Abscess K51.318 Ulcerative (Chronic) Rectosigmoiditis With Other Complication K51.319 Ulcerative (Chronic) Rectosigmoiditis With Unspecified Complications K51.40 Inflammatory Polyps Of Colon Without Complications K51.411 Inflammatory Polyps Of Colon With Rectal Bleeding K51.412 Inflammatory Polyps Of Colon With Intestinal Obstruction K51.413 Inflammatory Polyps Of Colon With Fistula K51.414 Inflammatory Polyps Of Colon With Abscess K51.418 Inflammatory Polyps Of Colon With Other Complication K51.419 Inflammatory Polyps Of Colon With Unspecified Complications K51.50 Left Sided Colitis Without Complications K51.511 Left Sided Colitis With Rectal Bleeding K51.512 Left Sided Colitis With Intestinal Obstruction K51.513 Left Sided Colitis With Fistula K51.514 Left Sided Colitis With Abscess K51.518 Left Sided Colitis With Other Complication

Page 36: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

K51.519 Left Sided Colitis With Unspecified Complications K51.80 Other Ulcerative Colitis Without Complications K51.80 Other Ulcerative Colitis Without Complications K51.811 Other Ulcerative Colitis With Rectal Bleeding K51.812 Other Ulcerative Colitis With Intestinal Obstruction K51.813 Other Ulcerative Colitis With Fistula K51.814 Other Ulcerative Colitis With Abscess K51.818 Other Ulcerative Colitis With Other Complication K51.819 Other Ulcerative Colitis With Unspecified Complications K51.90 Ulcerative Colitis, Unspecified, Without Complications K51.911 Ulcerative Colitis, Unspecified With Rectal Bleeding K51.912 Ulcerative Colitis, Unspecified With Intestinal Obstruction K51.913 Ulcerative Colitis, Unspecified With Fistula K51.914 Ulcerative Colitis, Unspecified With Abscess K51.918 Ulcerative Colitis, Unspecified With Other Complication K51.919 Ulcerative Colitis, Unspecified With Unspecified Complications

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity: HCPCS Codes HCPCS codes: Code Description J0135 Injection, adalimumab, 20 mg (Humira®)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description K50.00 Crohn's disease of small intestine without complications K50.011 Crohn's disease of small intestine with rectal bleeding K50.012 Crohn's disease of small intestine with intestinal obstruction K50.013 Crohn's disease of small intestine with fistula K50.014 Crohn's disease of small intestine with abscess K50.018 Crohn's disease of small intestine with other complication K50.019 Crohn's disease of small intestine with unspecified complications K50.10 Crohn's disease of large intestine without complications K50.111 Crohn's disease of large intestine with rectal bleeding K50.112 Crohn's disease of large intestine with intestinal obstruction K50.113 Crohn's disease of large intestine with fistula K50.114 Crohn's disease of large intestine with abscess K50.118 Crohn's disease of large intestine with other complication K50.119 Crohn's disease of large intestine with unspecified complications K50.80 Crohn's disease of both small and large intestine without complications K50.811 Crohn's disease of both small and large intestine with rectal bleeding K50.812 Crohn's disease of both small and large intestine with intestinal obstruction K50.813 Crohn's disease of both small and large intestine with fistula K50.814 Crohn's disease of both small and large intestine with abscess K50.818 Crohn's disease of both small and large intestine with other complication K50.819 Crohn's disease of both small and large intestine with unspecified complications K50.90 Crohn's disease, unspecified, without complications

Page 37: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

K50.911 Crohn's disease, unspecified, with rectal bleeding K50.912 Crohn's disease, unspecified, with intestinal obstruction K50.913 Crohn's disease, unspecified, with fistula K50.914 Crohn's disease, unspecified, with abscess K50.918 Crohn's disease, unspecified, with other complication K50.919 Crohn's disease, unspecified, with unspecified complications K51.00 Ulcerative (Chronic) Pancolitis Without Complications K51.011 Ulcerative (Chronic) Pancolitis With Rectal Bleeding K51.012 Ulcerative (Chronic) Pancolitis With Intestinal Obstruction K51.013 Ulcerative (Chronic) Pancolitis With Fistula K51.014 Ulcerative (Chronic) Pancolitis With Abscess K51.018 Ulcerative (Chronic) Pancolitis With Other Complication K51.019 Ulcerative (Chronic) Pancolitis With Unspecified Complications K51.20 Ulcerative (Chronic) Proctitis Without Complications K51.211 Ulcerative (Chronic) Proctitis With Rectal Bleeding K51.212 Ulcerative (Chronic) Proctitis With Intestinal Obstruction K51.213 Ulcerative (Chronic) Proctitis With Fistula K51.214 Ulcerative (Chronic) Proctitis With Abscess K51.218 Ulcerative (Chronic) Proctitis With Other Complication K51.219 Ulcerative (Chronic) Proctitis With Unspecified Complications K51.30 Ulcerative (Chronic) Rectosigmoiditis Without Complications K51.311 Ulcerative (Chronic) Rectosigmoiditis With Rectal Bleeding K51.312 Ulcerative (Chronic) Rectosigmoiditis With Intestinal Obstruction K51.313 Ulcerative (Chronic) Rectosigmoiditis With Fistula K51.314 Ulcerative (Chronic) Rectosigmoiditis With Abscess K51.318 Ulcerative (Chronic) Rectosigmoiditis With Other Complication K51.319 Ulcerative (Chronic) Rectosigmoiditis With Unspecified Complications K51.40 Inflammatory Polyps Of Colon Without Complications K51.411 Inflammatory Polyps Of Colon With Rectal Bleeding K51.412 Inflammatory Polyps Of Colon With Intestinal Obstruction K51.413 Inflammatory Polyps Of Colon With Fistula K51.414 Inflammatory Polyps Of Colon With Abscess K51.418 Inflammatory Polyps Of Colon With Other Complication K51.419 Inflammatory Polyps Of Colon With Unspecified Complications K51.50 Left Sided Colitis Without Complications K51.511 Left Sided Colitis With Rectal Bleeding K51.512 Left Sided Colitis With Intestinal Obstruction K51.513 Left Sided Colitis With Fistula K51.514 Left Sided Colitis With Abscess K51.518 Left Sided Colitis With Other Complication K51.519 Left Sided Colitis With Unspecified Complications K51.80 Other Ulcerative Colitis Without Complications K51.80 Other Ulcerative Colitis Without Complications K51.811 Other Ulcerative Colitis With Rectal Bleeding K51.812 Other Ulcerative Colitis With Intestinal Obstruction K51.813 Other Ulcerative Colitis With Fistula K51.814 Other Ulcerative Colitis With Abscess K51.818 Other Ulcerative Colitis With Other Complication K51.819 Other Ulcerative Colitis With Unspecified Complications K51.90 Ulcerative Colitis, Unspecified, Without Complications K51.911 Ulcerative Colitis, Unspecified With Rectal Bleeding K51.912 Ulcerative Colitis, Unspecified With Intestinal Obstruction K51.913 Ulcerative Colitis, Unspecified With Fistula K51.914 Ulcerative Colitis, Unspecified With Abscess K51.918 Ulcerative Colitis, Unspecified With Other Complication K51.919 Ulcerative Colitis, Unspecified With Unspecified Complications

Page 38: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

L73.2 Hidradentitis Supprative L40.0 Psoriasis vulgaris L40.50 Arthropathic psoriasis, unspecified L40.51 Distal interphalangeal psoriatic arthropathy L40.52 Psoriatic arthritis mutilans L40.59 Other psoriatic arthropathy M05.00 Felty's syndrome, unspecified site M05.011 Felty's syndrome, right shoulder M05.012 Felty's syndrome, left shoulder M05.019 Felty's syndrome, unspecified shoulder M05.021 Felty's syndrome, right elbow M05.022 Felty's syndrome, left elbow M05.029 Felty's syndrome, unspecified elbow M05.031 Felty's syndrome, right wrist M05.032 Felty's syndrome, left wrist M05.039 Felty's syndrome, unspecified wrist M05.041 Felty's syndrome, right hand M05.042 Felty's syndrome, left hand M05.049 Felty's syndrome, unspecified hand M05.051 Felty's syndrome, right hip M05.052 Felty's syndrome, left hip M05.059 Felty's syndrome, unspecified hip M05.061 Felty's syndrome, right knee M05.062 Felty's syndrome, left knee M05.069 Felty's syndrome, unspecified knee M05.071 Felty's syndrome, right ankle and foot M05.072 Felty's syndrome, left ankle and foot M05.079 Felty's syndrome, unspecified ankle and foot M05.09 Felty's syndrome, multiple sites M05.20 Rheumatoid vasculitis with rheumatoid arthritis of unspecified site M05.211 Rheumatoid vasculitis with rheumatoid arthritis of right shoulder M05.212 Rheumatoid vasculitis with rheumatoid arthritis of left shoulder M05.219 Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder M05.221 Rheumatoid vasculitis with rheumatoid arthritis of right elbow M05.222 Rheumatoid vasculitis with rheumatoid arthritis of left elbow M05.229 Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow M05.231 Rheumatoid vasculitis with rheumatoid arthritis of right wrist M05.232 Rheumatoid vasculitis with rheumatoid arthritis of left wrist M05.239 Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist M05.241 Rheumatoid vasculitis with rheumatoid arthritis of right hand M05.242 Rheumatoid vasculitis with rheumatoid arthritis of left hand M05.249 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand M05.251 Rheumatoid vasculitis with rheumatoid arthritis of right hip M05.252 Rheumatoid vasculitis with rheumatoid arthritis of left hip M05.259 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip M05.261 Rheumatoid vasculitis with rheumatoid arthritis of right knee M05.262 Rheumatoid vasculitis with rheumatoid arthritis of left knee M05.269 Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee M05.271 Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot M05.272 Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot M05.279 Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot M05.29 Rheumatoid vasculitis with rheumatoid arthritis of multiple sites M05.30 Rheumatoid heart disease with rheumatoid arthritis of unspecified site M05.311 Rheumatoid heart disease with rheumatoid arthritis of right shoulder M05.312 Rheumatoid heart disease with rheumatoid arthritis of left shoulder M05.319 Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder

Page 39: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.321 Rheumatoid heart disease with rheumatoid arthritis of right elbow M05.322 Rheumatoid heart disease with rheumatoid arthritis of left elbow M05.329 Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow M05.331 Rheumatoid heart disease with rheumatoid arthritis of right wrist M05.332 Rheumatoid heart disease with rheumatoid arthritis of left wrist M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist M05.341 Rheumatoid heart disease with rheumatoid arthritis of right hand M05.342 Rheumatoid heart disease with rheumatoid arthritis of left hand M05.349 Rheumatoid heart disease with rheumatoid arthritis of unspecified hand M05.351 Rheumatoid heart disease with rheumatoid arthritis of right hip M05.352 Rheumatoid heart disease with rheumatoid arthritis of left hip M05.359 Rheumatoid heart disease with rheumatoid arthritis of unspecified hip M05.361 Rheumatoid heart disease with rheumatoid arthritis of right knee M05.362 Rheumatoid heart disease with rheumatoid arthritis of left knee M05.369 Rheumatoid heart disease with rheumatoid arthritis of unspecified knee M05.371 Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot M05.372 Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot M05.379 Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot M05.39 Rheumatoid heart disease with rheumatoid arthritis of multiple sites M05.40 Rheumatoid myopathy with rheumatoid arthritis of unspecified site M05.411 Rheumatoid myopathy with rheumatoid arthritis of right shoulder M05.412 Rheumatoid myopathy with rheumatoid arthritis of left shoulder M05.419 Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder M05.421 Rheumatoid myopathy with rheumatoid arthritis of right elbow M05.422 Rheumatoid myopathy with rheumatoid arthritis of left elbow M05.429 Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow M05.431 Rheumatoid myopathy with rheumatoid arthritis of right wrist M05.432 Rheumatoid myopathy with rheumatoid arthritis of left wrist M05.439 Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist M05.441 Rheumatoid myopathy with rheumatoid arthritis of right hand M05.442 Rheumatoid myopathy with rheumatoid arthritis of left hand M05.449 Rheumatoid myopathy with rheumatoid arthritis of unspecified hand M05.451 Rheumatoid myopathy with rheumatoid arthritis of right hip M05.452 Rheumatoid myopathy with rheumatoid arthritis of left hip M05.459 Rheumatoid myopathy with rheumatoid arthritis of unspecified hip M05.461 Rheumatoid myopathy with rheumatoid arthritis of right knee M05.462 Rheumatoid myopathy with rheumatoid arthritis of left knee M05.469 Rheumatoid myopathy with rheumatoid arthritis of unspecified knee M05.471 Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot M05.472 Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot M05.479 Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot M05.49 Rheumatoid myopathy with rheumatoid arthritis of multiple sites M05.50 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site M05.511 Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder M05.512 Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder M05.519 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder M05.521 Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow M05.522 Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow M05.529 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow M05.531 Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist M05.532 Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist M05.539 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist M05.541 Rheumatoid polyneuropathy with rheumatoid arthritis of right hand M05.542 Rheumatoid polyneuropathy with rheumatoid arthritis of left hand M05.549 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand M05.551 Rheumatoid polyneuropathy with rheumatoid arthritis of right hip

Page 40: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.552 Rheumatoid polyneuropathy with rheumatoid arthritis of left hip M05.559 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip M05.561 Rheumatoid polyneuropathy with rheumatoid arthritis of right knee M05.562 Rheumatoid polyneuropathy with rheumatoid arthritis of left knee M05.569 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee M05.571 Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot M05.572 Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot M05.579 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot M05.59 Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites M05.60 Rheumatoid arthritis of unspecified site with involvement of other organs and systems M05.611 Rheumatoid arthritis of right shoulder with involvement of other organs and systems M05.612 Rheumatoid arthritis of left shoulder with involvement of other organs and systems

M05.619 Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

M05.621 Rheumatoid arthritis of right elbow with involvement of other organs and systems M05.622 Rheumatoid arthritis of left elbow with involvement of other organs and systems

M05.629 Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems

M05.631 Rheumatoid arthritis of right wrist with involvement of other organs and systems M05.632 Rheumatoid arthritis of left wrist with involvement of other organs and systems M05.639 Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems M05.641 Rheumatoid arthritis of right hand with involvement of other organs and systems M05.642 Rheumatoid arthritis of left hand with involvement of other organs and systems M05.649 Rheumatoid arthritis of unspecified hand with involvement of other organs and systems M05.651 Rheumatoid arthritis of right hip with involvement of other organs and systems M05.652 Rheumatoid arthritis of left hip with involvement of other organs and systems M05.659 Rheumatoid arthritis of unspecified hip with involvement of other organs and systems M05.661 Rheumatoid arthritis of right knee with involvement of other organs and systems M05.662 Rheumatoid arthritis of left knee with involvement of other organs and systems M05.669 Rheumatoid arthritis of unspecified knee with involvement of other organs and systems

M05.671 Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems

M05.672 Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems

M05.679 Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems

M05.69 Rheumatoid arthritis of multiple sites with involvement of other organs and systems

M05.70 Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement

M05.711 Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement

M05.712 Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement

M05.719 Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement

M05.721 Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement

M05.722 Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement

M05.729 Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement

M05.731 Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement

M05.732 Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement

M05.739 Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement

M05.741 Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems

Page 41: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

involvement

M05.742 Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement

M05.749 Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement

M05.751 Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement

M05.752 Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement

M05.759 Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement

M05.761 Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement

M05.762 Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement

M05.769 Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement

M05.771 Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement

M05.772 Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement

M05.779 Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement

M05.79 Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement

M05.80 Other rheumatoid arthritis with rheumatoid factor of unspecified site M05.811 Other rheumatoid arthritis with rheumatoid factor of right shoulder M05.812 Other rheumatoid arthritis with rheumatoid factor of left shoulder M05.819 Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder M05.821 Other rheumatoid arthritis with rheumatoid factor of right elbow M05.822 Other rheumatoid arthritis with rheumatoid factor of left elbow M05.829 Other rheumatoid arthritis with rheumatoid factor of unspecified elbow M05.831 Other rheumatoid arthritis with rheumatoid factor of right wrist M05.832 Other rheumatoid arthritis with rheumatoid factor of left wrist M05.839 Other rheumatoid arthritis with rheumatoid factor of unspecified wrist M05.841 Other rheumatoid arthritis with rheumatoid factor of right hand M05.842 Other rheumatoid arthritis with rheumatoid factor of left hand M05.849 Other rheumatoid arthritis with rheumatoid factor of unspecified hand M05.851 Other rheumatoid arthritis with rheumatoid factor of right hip M05.852 Other rheumatoid arthritis with rheumatoid factor of left hip M05.859 Other rheumatoid arthritis with rheumatoid factor of unspecified hip M05.861 Other rheumatoid arthritis with rheumatoid factor of right knee M05.862 Other rheumatoid arthritis with rheumatoid factor of left knee M05.869 Other rheumatoid arthritis with rheumatoid factor of unspecified knee M05.871 Other rheumatoid arthritis with rheumatoid factor of right ankle and foot M05.872 Other rheumatoid arthritis with rheumatoid factor of left ankle and foot M05.879 Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot M05.89 Other rheumatoid arthritis with rheumatoid factor of multiple sites M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.011 Rheumatoid arthritis without rheumatoid factor, right shoulder M06.012 Rheumatoid arthritis without rheumatoid factor, left shoulder M06.019 Rheumatoid arthritis without rheumatoid factor, unspecified shoulder M06.021 Rheumatoid arthritis without rheumatoid factor, right elbow M06.022 Rheumatoid arthritis without rheumatoid factor, left elbow M06.029 Rheumatoid arthritis without rheumatoid factor, unspecified elbow M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist

Page 42: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist M06.039 Rheumatoid arthritis without rheumatoid factor, unspecified wrist M06.041 Rheumatoid arthritis without rheumatoid factor, right hand M06.042 Rheumatoid arthritis without rheumatoid factor, left hand M06.049 Rheumatoid arthritis without rheumatoid factor, unspecified hand M06.051 Rheumatoid arthritis without rheumatoid factor, right hip M06.052 Rheumatoid arthritis without rheumatoid factor, left hip M06.059 Rheumatoid arthritis without rheumatoid factor, unspecified hip M06.061 Rheumatoid arthritis without rheumatoid factor, right knee M06.062 Rheumatoid arthritis without rheumatoid factor, left knee M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee M06.071 Rheumatoid arthritis without rheumatoid factor, right ankle and foot M06.072 Rheumatoid arthritis without rheumatoid factor, left ankle and foot M06.079 Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot M06.08 Rheumatoid arthritis without rheumatoid factor, vertebrae M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites M06.1 Adult-onset Still's disease M06.80 Other specified rheumatoid arthritis, unspecified site M06.811 Other specified rheumatoid arthritis, right shoulder M06.812 Other specified rheumatoid arthritis, left shoulder M06.819 Other specified rheumatoid arthritis, unspecified shoulder M06.821 Other specified rheumatoid arthritis, right elbow M06.822 Other specified rheumatoid arthritis, left elbow M06.829 Other specified rheumatoid arthritis, unspecified elbow M06.831 Other specified rheumatoid arthritis, right wrist M06.832 Other specified rheumatoid arthritis, left wrist M06.839 Other specified rheumatoid arthritis, unspecified wrist M06.841 Other specified rheumatoid arthritis, right hand M06.842 Other specified rheumatoid arthritis, left hand M06.849 Other specified rheumatoid arthritis, unspecified hand M06.851 Other specified rheumatoid arthritis, right hip M06.852 Other specified rheumatoid arthritis, left hip M06.859 Other specified rheumatoid arthritis, unspecified hip M06.861 Other specified rheumatoid arthritis, right knee M06.862 Other specified rheumatoid arthritis, left knee M06.869 Other specified rheumatoid arthritis, unspecified knee M06.871 Other specified rheumatoid arthritis, right ankle and foot M06.872 Other specified rheumatoid arthritis, left ankle and foot M06.879 Other specified rheumatoid arthritis, unspecified ankle and foot M06.88 Other specified rheumatoid arthritis, vertebrae M06.89 Other specified rheumatoid arthritis, multiple sites M06.9 Rheumatoid arthritis, unspecified M08.00 Unspecified juvenile rheumatoid arthritis of unspecified site M08.011 Unspecified juvenile rheumatoid arthritis, right shoulder M08.012 Unspecified juvenile rheumatoid arthritis, left shoulder M08.019 Unspecified juvenile rheumatoid arthritis, unspecified shoulder M08.021 Unspecified juvenile rheumatoid arthritis, right elbow M08.022 Unspecified juvenile rheumatoid arthritis, left elbow M08.029 Unspecified juvenile rheumatoid arthritis, unspecified elbow M08.031 Unspecified juvenile rheumatoid arthritis, right wrist M08.032 Unspecified juvenile rheumatoid arthritis, left wrist M08.039 Unspecified juvenile rheumatoid arthritis, unspecified wrist M08.041 Unspecified juvenile rheumatoid arthritis, right hand M08.042 Unspecified juvenile rheumatoid arthritis, left hand M08.049 Unspecified juvenile rheumatoid arthritis, unspecified hand M08.051 Unspecified juvenile rheumatoid arthritis, right hip

Page 43: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.052 Unspecified juvenile rheumatoid arthritis, left hip M08.059 Unspecified juvenile rheumatoid arthritis, unspecified hip M08.061 Unspecified juvenile rheumatoid arthritis, right knee M08.062 Unspecified juvenile rheumatoid arthritis, left knee M08.069 Unspecified juvenile rheumatoid arthritis, unspecified knee M08.071 Unspecified juvenile rheumatoid arthritis, right ankle and foot M08.072 Unspecified juvenile rheumatoid arthritis, left ankle and foot M08.079 Unspecified juvenile rheumatoid arthritis, unspecified ankle and foot M08.08 Unspecified juvenile rheumatoid arthritis, vertebrae M08.09 Unspecified juvenile rheumatoid arthritis, multiple sites M08.20 Juvenile rheumatoid arthritis with systemic onset, unspecified site M08.211 Juvenile rheumatoid arthritis with systemic onset, right shoulder M08.212 Juvenile rheumatoid arthritis with systemic onset, left shoulder M08.219 Juvenile rheumatoid arthritis with systemic onset, unspecified shoulder M08.221 Juvenile rheumatoid arthritis with systemic onset, right elbow M08.222 Juvenile rheumatoid arthritis with systemic onset, left elbow M08.229 Juvenile rheumatoid arthritis with systemic onset, unspecified elbow M08.231 Juvenile rheumatoid arthritis with systemic onset, right wrist M08.232 Juvenile rheumatoid arthritis with systemic onset, left wrist M08.239 Juvenile rheumatoid arthritis with systemic onset, unspecified wrist M08.241 Juvenile rheumatoid arthritis with systemic onset, right hand M08.242 Juvenile rheumatoid arthritis with systemic onset, left hand M08.249 Juvenile rheumatoid arthritis with systemic onset, unspecified hand M08.251 Juvenile rheumatoid arthritis with systemic onset, right hip M08.252 Juvenile rheumatoid arthritis with systemic onset, left hip M08.259 Juvenile rheumatoid arthritis with systemic onset, unspecified hip M08.261 Juvenile rheumatoid arthritis with systemic onset, right knee M08.262 Juvenile rheumatoid arthritis with systemic onset, left knee M08.269 Juvenile rheumatoid arthritis with systemic onset, unspecified knee M08.271 Juvenile rheumatoid arthritis with systemic onset, right ankle and foot M08.272 Juvenile rheumatoid arthritis with systemic onset, left ankle and foot M08.279 Juvenile rheumatoid arthritis with systemic onset, unspecified ankle and foot M08.28 Juvenile rheumatoid arthritis with systemic onset, vertebrae M08.29 Juvenile rheumatoid arthritis with systemic onset, multiple sites M08.3 Juvenile rheumatoid polyarthritis (seronegative) M08.40 Pauciarticular juvenile rheumatoid arthritis, unspecified site M08.411 Pauciarticular juvenile rheumatoid arthritis, right shoulder M08.412 Pauciarticular juvenile rheumatoid arthritis, left shoulder M08.419 Pauciarticular juvenile rheumatoid arthritis, unspecified shoulder M08.421 Pauciarticular juvenile rheumatoid arthritis, right elbow M08.422 Pauciarticular juvenile rheumatoid arthritis, left elbow M08.429 Pauciarticular juvenile rheumatoid arthritis, unspecified elbow M08.431 Pauciarticular juvenile rheumatoid arthritis, right wrist M08.432 Pauciarticular juvenile rheumatoid arthritis, left wrist M08.439 Pauciarticular juvenile rheumatoid arthritis, unspecified wrist M08.441 Pauciarticular juvenile rheumatoid arthritis, right hand M08.442 Pauciarticular juvenile rheumatoid arthritis, left hand M08.449 Pauciarticular juvenile rheumatoid arthritis, unspecified hand M08.451 Pauciarticular juvenile rheumatoid arthritis, right hip M08.452 Pauciarticular juvenile rheumatoid arthritis, left hip M08.459 Pauciarticular juvenile rheumatoid arthritis, unspecified hip M08.461 Pauciarticular juvenile rheumatoid arthritis, right knee M08.462 Pauciarticular juvenile rheumatoid arthritis, left knee M08.469 Pauciarticular juvenile rheumatoid arthritis, unspecified knee M08.471 Pauciarticular juvenile rheumatoid arthritis, right ankle and foot M08.472 Pauciarticular juvenile rheumatoid arthritis, left ankle and foot

Page 44: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.479 Pauciarticular juvenile rheumatoid arthritis, unspecified ankle and foot M08.48 Pauciarticular juvenile rheumatoid arthritis, vertebrae M08.80 Other juvenile arthritis, unspecified site M08.811 Other juvenile arthritis, right shoulder M08.812 Other juvenile arthritis, left shoulder M08.819 Other juvenile arthritis, unspecified shoulder M08.821 Other juvenile arthritis, right elbow M08.822 Other juvenile arthritis, left elbow M08.829 Other juvenile arthritis, unspecified elbow M08.831 Other juvenile arthritis, right wrist M08.832 Other juvenile arthritis, left wrist M08.839 Other juvenile arthritis, unspecified wrist M08.841 Other juvenile arthritis, right hand M08.842 Other juvenile arthritis, left hand M08.849 Other juvenile arthritis, unspecified hand M08.851 Other juvenile arthritis, right hip M08.852 Other juvenile arthritis, left hip M08.859 Other juvenile arthritis, unspecified hip M08.861 Other juvenile arthritis, right knee M08.862 Other juvenile arthritis, left knee M08.869 Other juvenile arthritis, unspecified knee M08.871 Other juvenile arthritis, right ankle and foot M08.872 Other juvenile arthritis, left ankle and foot M08.879 Other juvenile arthritis, unspecified ankle and foot M08.88 Other juvenile arthritis, other specified site M08.89 Other juvenile arthritis, multiple sites M08.90 Juvenile arthritis, unspecified, unspecified site M08.911 Juvenile arthritis, unspecified, right shoulder M08.912 Juvenile arthritis, unspecified, left shoulder M08.919 Juvenile arthritis, unspecified, unspecified shoulder M08.921 Juvenile arthritis, unspecified, right elbow M08.922 Juvenile arthritis, unspecified, left elbow M08.929 Juvenile arthritis, unspecified, unspecified elbow M08.931 Juvenile arthritis, unspecified, right wrist M08.932 Juvenile arthritis, unspecified, left wrist M08.939 Juvenile arthritis, unspecified, unspecified wrist M08.941 Juvenile arthritis, unspecified, right hand M08.942 Juvenile arthritis, unspecified, left hand M08.949 Juvenile arthritis, unspecified, unspecified hand M08.951 Juvenile arthritis, unspecified, right hip M08.952 Juvenile arthritis, unspecified, left hip M08.959 Juvenile arthritis, unspecified, unspecified hip M08.961 Juvenile arthritis, unspecified, right knee M08.962 Juvenile arthritis, unspecified, left knee M08.969 Juvenile arthritis, unspecified, unspecified knee M08.971 Juvenile arthritis, unspecified, right ankle and foot M08.972 Juvenile arthritis, unspecified, left ankle and foot M08.979 Juvenile arthritis, unspecified, unspecified ankle and foot M08.98 Juvenile arthritis, unspecified, vertebrae M08.99 Juvenile arthritis, unspecified, multiple sites M45.0 Ankylosing spondylitis of multiple sites in spine M45.1 Ankylosing spondylitis of occipito-atlanto-axial region M45.2 Ankylosing spondylitis of cervical region M45.3 Ankylosing spondylitis of cervicothoracic region M45.4 Ankylosing spondylitis of thoracic region M45.5 Ankylosing spondylitis of thoracolumbar region

Page 45: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M45.6 Ankylosing spondylitis lumbar region M45.7 Ankylosing spondylitis of lumbosacral region M45.8 Ankylosing spondylitis sacral and sacrococcygeal region M45.9 Ankylosing spondylitis of unspecified sites in spine

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity: HCPCS Codes HCPCS codes: Code Description J0129 Injection, abatacept, 10 mg (Orencia®)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description M05.00 Felty's syndrome, unspecified site M05.011 Felty's syndrome, right shoulder M05.012 Felty's syndrome, left shoulder M05.019 Felty's syndrome, unspecified shoulder M05.021 Felty's syndrome, right elbow M05.022 Felty's syndrome, left elbow M05.029 Felty's syndrome, unspecified elbow M05.031 Felty's syndrome, right wrist M05.032 Felty's syndrome, left wrist M05.039 Felty's syndrome, unspecified wrist M05.041 Felty's syndrome, right hand M05.042 Felty's syndrome, left hand M05.049 Felty's syndrome, unspecified hand M05.051 Felty's syndrome, right hip M05.052 Felty's syndrome, left hip M05.059 Felty's syndrome, unspecified hip M05.061 Felty's syndrome, right knee M05.062 Felty's syndrome, left knee M05.069 Felty's syndrome, unspecified knee M05.071 Felty's syndrome, right ankle and foot M05.072 Felty's syndrome, left ankle and foot M05.079 Felty's syndrome, unspecified ankle and foot M05.09 Felty's syndrome, multiple sites M05.20 Rheumatoid vasculitis with rheumatoid arthritis of unspecified site M05.211 Rheumatoid vasculitis with rheumatoid arthritis of right shoulder M05.212 Rheumatoid vasculitis with rheumatoid arthritis of left shoulder M05.219 Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder M05.221 Rheumatoid vasculitis with rheumatoid arthritis of right elbow M05.222 Rheumatoid vasculitis with rheumatoid arthritis of left elbow M05.229 Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow M05.231 Rheumatoid vasculitis with rheumatoid arthritis of right wrist M05.232 Rheumatoid vasculitis with rheumatoid arthritis of left wrist M05.239 Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist M05.241 Rheumatoid vasculitis with rheumatoid arthritis of right hand M05.242 Rheumatoid vasculitis with rheumatoid arthritis of left hand M05.249 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand M05.251 Rheumatoid vasculitis with rheumatoid arthritis of right hip

Page 46: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.252 Rheumatoid vasculitis with rheumatoid arthritis of left hip M05.259 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip M05.261 Rheumatoid vasculitis with rheumatoid arthritis of right knee M05.262 Rheumatoid vasculitis with rheumatoid arthritis of left knee M05.269 Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee M05.271 Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot M05.272 Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot M05.279 Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot M05.29 Rheumatoid vasculitis with rheumatoid arthritis of multiple sites M05.30 Rheumatoid heart disease with rheumatoid arthritis of unspecified site M05.311 Rheumatoid heart disease with rheumatoid arthritis of right shoulder M05.312 Rheumatoid heart disease with rheumatoid arthritis of left shoulder M05.319 Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder M05.321 Rheumatoid heart disease with rheumatoid arthritis of right elbow M05.322 Rheumatoid heart disease with rheumatoid arthritis of left elbow M05.329 Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow M05.331 Rheumatoid heart disease with rheumatoid arthritis of right wrist M05.332 Rheumatoid heart disease with rheumatoid arthritis of left wrist M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist M05.341 Rheumatoid heart disease with rheumatoid arthritis of right hand M05.342 Rheumatoid heart disease with rheumatoid arthritis of left hand M05.349 Rheumatoid heart disease with rheumatoid arthritis of unspecified hand M05.351 Rheumatoid heart disease with rheumatoid arthritis of right hip M05.352 Rheumatoid heart disease with rheumatoid arthritis of left hip M05.359 Rheumatoid heart disease with rheumatoid arthritis of unspecified hip M05.361 Rheumatoid heart disease with rheumatoid arthritis of right knee M05.362 Rheumatoid heart disease with rheumatoid arthritis of left knee M05.369 Rheumatoid heart disease with rheumatoid arthritis of unspecified knee M05.371 Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot M05.372 Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot M05.379 Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot M05.39 Rheumatoid heart disease with rheumatoid arthritis of multiple sites M05.40 Rheumatoid myopathy with rheumatoid arthritis of unspecified site M05.411 Rheumatoid myopathy with rheumatoid arthritis of right shoulder M05.412 Rheumatoid myopathy with rheumatoid arthritis of left shoulder M05.419 Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder M05.421 Rheumatoid myopathy with rheumatoid arthritis of right elbow M05.422 Rheumatoid myopathy with rheumatoid arthritis of left elbow M05.429 Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow M05.431 Rheumatoid myopathy with rheumatoid arthritis of right wrist M05.432 Rheumatoid myopathy with rheumatoid arthritis of left wrist M05.439 Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist M05.441 Rheumatoid myopathy with rheumatoid arthritis of right hand M05.442 Rheumatoid myopathy with rheumatoid arthritis of left hand M05.449 Rheumatoid myopathy with rheumatoid arthritis of unspecified hand M05.451 Rheumatoid myopathy with rheumatoid arthritis of right hip M05.452 Rheumatoid myopathy with rheumatoid arthritis of left hip M05.459 Rheumatoid myopathy with rheumatoid arthritis of unspecified hip M05.461 Rheumatoid myopathy with rheumatoid arthritis of right knee M05.462 Rheumatoid myopathy with rheumatoid arthritis of left knee M05.469 Rheumatoid myopathy with rheumatoid arthritis of unspecified knee M05.471 Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot M05.472 Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot M05.479 Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot M05.49 Rheumatoid myopathy with rheumatoid arthritis of multiple sites M05.50 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site

Page 47: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.511 Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder M05.512 Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder M05.519 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder M05.521 Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow M05.522 Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow M05.529 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow M05.531 Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist M05.532 Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist M05.539 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist M05.541 Rheumatoid polyneuropathy with rheumatoid arthritis of right hand M05.542 Rheumatoid polyneuropathy with rheumatoid arthritis of left hand M05.549 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand M05.551 Rheumatoid polyneuropathy with rheumatoid arthritis of right hip M05.552 Rheumatoid polyneuropathy with rheumatoid arthritis of left hip M05.559 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip M05.561 Rheumatoid polyneuropathy with rheumatoid arthritis of right knee M05.562 Rheumatoid polyneuropathy with rheumatoid arthritis of left knee M05.569 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee M05.571 Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot M05.572 Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot M05.579 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot M05.59 Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites M05.60 Rheumatoid arthritis of unspecified site with involvement of other organs and systems M05.611 Rheumatoid arthritis of right shoulder with involvement of other organs and systems M05.612 Rheumatoid arthritis of left shoulder with involvement of other organs and systems

M05.619 Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

M05.621 Rheumatoid arthritis of right elbow with involvement of other organs and systems M05.622 Rheumatoid arthritis of left elbow with involvement of other organs and systems

M05.629 Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems

M05.631 Rheumatoid arthritis of right wrist with involvement of other organs and systems M05.632 Rheumatoid arthritis of left wrist with involvement of other organs and systems M05.639 Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems M05.641 Rheumatoid arthritis of right hand with involvement of other organs and systems M05.642 Rheumatoid arthritis of left hand with involvement of other organs and systems M05.649 Rheumatoid arthritis of unspecified hand with involvement of other organs and systems M05.651 Rheumatoid arthritis of right hip with involvement of other organs and systems M05.652 Rheumatoid arthritis of left hip with involvement of other organs and systems M05.659 Rheumatoid arthritis of unspecified hip with involvement of other organs and systems M05.661 Rheumatoid arthritis of right knee with involvement of other organs and systems M05.662 Rheumatoid arthritis of left knee with involvement of other organs and systems M05.669 Rheumatoid arthritis of unspecified knee with involvement of other organs and systems

M05.671 Rheumatoid arthritis of right ankle and foot with involvement of other organs and systems

M05.672 Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems

M05.679 Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems

M05.69 Rheumatoid arthritis of multiple sites with involvement of other organs and systems

M05.70 Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement

M05.711 Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement

M05.712 Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement

M05.719 Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or

Page 48: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

systems involvement

M05.721 Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement

M05.722 Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement

M05.729 Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement

M05.731 Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement

M05.732 Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement

M05.739 Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement

M05.741 Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement

M05.742 Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement

M05.749 Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement

M05.751 Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement

M05.752 Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement

M05.759 Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement

M05.761 Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement

M05.762 Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement

M05.769 Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement

M05.771 Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement

M05.772 Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement

M05.779 Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement

M05.79 Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement

M05.80 Other rheumatoid arthritis with rheumatoid factor of unspecified site M05.811 Other rheumatoid arthritis with rheumatoid factor of right shoulder M05.812 Other rheumatoid arthritis with rheumatoid factor of left shoulder M05.819 Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder M05.821 Other rheumatoid arthritis with rheumatoid factor of right elbow M05.822 Other rheumatoid arthritis with rheumatoid factor of left elbow M05.829 Other rheumatoid arthritis with rheumatoid factor of unspecified elbow M05.831 Other rheumatoid arthritis with rheumatoid factor of right wrist M05.832 Other rheumatoid arthritis with rheumatoid factor of left wrist M05.839 Other rheumatoid arthritis with rheumatoid factor of unspecified wrist M05.841 Other rheumatoid arthritis with rheumatoid factor of right hand M05.842 Other rheumatoid arthritis with rheumatoid factor of left hand M05.849 Other rheumatoid arthritis with rheumatoid factor of unspecified hand M05.851 Other rheumatoid arthritis with rheumatoid factor of right hip M05.852 Other rheumatoid arthritis with rheumatoid factor of left hip M05.859 Other rheumatoid arthritis with rheumatoid factor of unspecified hip M05.861 Other rheumatoid arthritis with rheumatoid factor of right knee M05.862 Other rheumatoid arthritis with rheumatoid factor of left knee M05.869 Other rheumatoid arthritis with rheumatoid factor of unspecified knee

Page 49: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.871 Other rheumatoid arthritis with rheumatoid factor of right ankle and foot M05.872 Other rheumatoid arthritis with rheumatoid factor of left ankle and foot M05.879 Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot M05.89 Other rheumatoid arthritis with rheumatoid factor of multiple sites M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.011 Rheumatoid arthritis without rheumatoid factor, right shoulder M06.012 Rheumatoid arthritis without rheumatoid factor, left shoulder M06.019 Rheumatoid arthritis without rheumatoid factor, unspecified shoulder M06.021 Rheumatoid arthritis without rheumatoid factor, right elbow M06.022 Rheumatoid arthritis without rheumatoid factor, left elbow M06.029 Rheumatoid arthritis without rheumatoid factor, unspecified elbow M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist M06.039 Rheumatoid arthritis without rheumatoid factor, unspecified wrist M06.041 Rheumatoid arthritis without rheumatoid factor, right hand M06.042 Rheumatoid arthritis without rheumatoid factor, left hand M06.049 Rheumatoid arthritis without rheumatoid factor, unspecified hand M06.051 Rheumatoid arthritis without rheumatoid factor, right hip M06.052 Rheumatoid arthritis without rheumatoid factor, left hip M06.059 Rheumatoid arthritis without rheumatoid factor, unspecified hip M06.061 Rheumatoid arthritis without rheumatoid factor, right knee M06.062 Rheumatoid arthritis without rheumatoid factor, left knee M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee M06.071 Rheumatoid arthritis without rheumatoid factor, right ankle and foot M06.072 Rheumatoid arthritis without rheumatoid factor, left ankle and foot M06.079 Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot M06.08 Rheumatoid arthritis without rheumatoid factor, vertebrae M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites M06.1 Adult-onset Still's disease M06.80 Other specified rheumatoid arthritis, unspecified site M06.811 Other specified rheumatoid arthritis, right shoulder M06.812 Other specified rheumatoid arthritis, left shoulder M06.819 Other specified rheumatoid arthritis, unspecified shoulder M06.821 Other specified rheumatoid arthritis, right elbow M06.822 Other specified rheumatoid arthritis, left elbow M06.829 Other specified rheumatoid arthritis, unspecified elbow M06.831 Other specified rheumatoid arthritis, right wrist M06.832 Other specified rheumatoid arthritis, left wrist M06.839 Other specified rheumatoid arthritis, unspecified wrist M06.841 Other specified rheumatoid arthritis, right hand M06.842 Other specified rheumatoid arthritis, left hand M06.849 Other specified rheumatoid arthritis, unspecified hand M06.851 Other specified rheumatoid arthritis, right hip M06.852 Other specified rheumatoid arthritis, left hip M06.859 Other specified rheumatoid arthritis, unspecified hip M06.861 Other specified rheumatoid arthritis, right knee M06.862 Other specified rheumatoid arthritis, left knee M06.869 Other specified rheumatoid arthritis, unspecified knee M06.871 Other specified rheumatoid arthritis, right ankle and foot M06.872 Other specified rheumatoid arthritis, left ankle and foot M06.879 Other specified rheumatoid arthritis, unspecified ankle and foot M06.88 Other specified rheumatoid arthritis, vertebrae M06.89 Other specified rheumatoid arthritis, multiple sites M06.9 Rheumatoid arthritis, unspecified M08.00 Unspecified juvenile rheumatoid arthritis of unspecified site

Page 50: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.011 Unspecified juvenile rheumatoid arthritis, right shoulder M08.012 Unspecified juvenile rheumatoid arthritis, left shoulder M08.019 Unspecified juvenile rheumatoid arthritis, unspecified shoulder M08.021 Unspecified juvenile rheumatoid arthritis, right elbow M08.022 Unspecified juvenile rheumatoid arthritis, left elbow M08.029 Unspecified juvenile rheumatoid arthritis, unspecified elbow M08.031 Unspecified juvenile rheumatoid arthritis, right wrist M08.032 Unspecified juvenile rheumatoid arthritis, left wrist M08.039 Unspecified juvenile rheumatoid arthritis, unspecified wrist M08.041 Unspecified juvenile rheumatoid arthritis, right hand M08.042 Unspecified juvenile rheumatoid arthritis, left hand M08.049 Unspecified juvenile rheumatoid arthritis, unspecified hand M08.051 Unspecified juvenile rheumatoid arthritis, right hip M08.052 Unspecified juvenile rheumatoid arthritis, left hip M08.059 Unspecified juvenile rheumatoid arthritis, unspecified hip M08.061 Unspecified juvenile rheumatoid arthritis, right knee M08.062 Unspecified juvenile rheumatoid arthritis, left knee M08.069 Unspecified juvenile rheumatoid arthritis, unspecified knee M08.071 Unspecified juvenile rheumatoid arthritis, right ankle and foot M08.072 Unspecified juvenile rheumatoid arthritis, left ankle and foot M08.079 Unspecified juvenile rheumatoid arthritis, unspecified ankle and foot M08.08 Unspecified juvenile rheumatoid arthritis, vertebrae M08.09 Unspecified juvenile rheumatoid arthritis, multiple sites M08.20 Juvenile rheumatoid arthritis with systemic onset, unspecified site M08.211 Juvenile rheumatoid arthritis with systemic onset, right shoulder M08.212 Juvenile rheumatoid arthritis with systemic onset, left shoulder M08.219 Juvenile rheumatoid arthritis with systemic onset, unspecified shoulder M08.221 Juvenile rheumatoid arthritis with systemic onset, right elbow M08.222 Juvenile rheumatoid arthritis with systemic onset, left elbow M08.229 Juvenile rheumatoid arthritis with systemic onset, unspecified elbow M08.231 Juvenile rheumatoid arthritis with systemic onset, right wrist M08.232 Juvenile rheumatoid arthritis with systemic onset, left wrist M08.239 Juvenile rheumatoid arthritis with systemic onset, unspecified wrist M08.241 Juvenile rheumatoid arthritis with systemic onset, right hand M08.242 Juvenile rheumatoid arthritis with systemic onset, left hand M08.249 Juvenile rheumatoid arthritis with systemic onset, unspecified hand M08.251 Juvenile rheumatoid arthritis with systemic onset, right hip M08.252 Juvenile rheumatoid arthritis with systemic onset, left hip M08.259 Juvenile rheumatoid arthritis with systemic onset, unspecified hip M08.261 Juvenile rheumatoid arthritis with systemic onset, right knee M08.262 Juvenile rheumatoid arthritis with systemic onset, left knee M08.269 Juvenile rheumatoid arthritis with systemic onset, unspecified knee M08.271 Juvenile rheumatoid arthritis with systemic onset, right ankle and foot M08.272 Juvenile rheumatoid arthritis with systemic onset, left ankle and foot M08.279 Juvenile rheumatoid arthritis with systemic onset, unspecified ankle and foot M08.28 Juvenile rheumatoid arthritis with systemic onset, vertebrae M08.29 Juvenile rheumatoid arthritis with systemic onset, multiple sites M08.3 Juvenile rheumatoid polyarthritis (seronegative) M08.80 Other juvenile arthritis, unspecified site M08.811 Other juvenile arthritis, right shoulder M08.812 Other juvenile arthritis, left shoulder M08.819 Other juvenile arthritis, unspecified shoulder M08.821 Other juvenile arthritis, right elbow M08.822 Other juvenile arthritis, left elbow M08.829 Other juvenile arthritis, unspecified elbow M08.831 Other juvenile arthritis, right wrist

Page 51: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M08.832 Other juvenile arthritis, left wrist M08.839 Other juvenile arthritis, unspecified wrist M08.841 Other juvenile arthritis, right hand M08.842 Other juvenile arthritis, left hand M08.849 Other juvenile arthritis, unspecified hand M08.851 Other juvenile arthritis, right hip M08.852 Other juvenile arthritis, left hip M08.859 Other juvenile arthritis, unspecified hip M08.861 Other juvenile arthritis, right knee M08.862 Other juvenile arthritis, left knee M08.869 Other juvenile arthritis, unspecified knee M08.871 Other juvenile arthritis, right ankle and foot M08.872 Other juvenile arthritis, left ankle and foot M08.879 Other juvenile arthritis, unspecified ankle and foot M08.88 Other juvenile arthritis, other specified site M08.89 Other juvenile arthritis, multiple sites M08.90 Juvenile arthritis, unspecified, unspecified site M08.911 Juvenile arthritis, unspecified, right shoulder M08.912 Juvenile arthritis, unspecified, left shoulder M08.919 Juvenile arthritis, unspecified, unspecified shoulder M08.921 Juvenile arthritis, unspecified, right elbow M08.922 Juvenile arthritis, unspecified, left elbow M08.929 Juvenile arthritis, unspecified, unspecified elbow M08.931 Juvenile arthritis, unspecified, right wrist M08.932 Juvenile arthritis, unspecified, left wrist M08.939 Juvenile arthritis, unspecified, unspecified wrist M08.941 Juvenile arthritis, unspecified, right hand M08.942 Juvenile arthritis, unspecified, left hand M08.949 Juvenile arthritis, unspecified, unspecified hand M08.951 Juvenile arthritis, unspecified, right hip M08.952 Juvenile arthritis, unspecified, left hip M08.959 Juvenile arthritis, unspecified, unspecified hip M08.961 Juvenile arthritis, unspecified, right knee M08.962 Juvenile arthritis, unspecified, left knee M08.969 Juvenile arthritis, unspecified, unspecified knee M08.971 Juvenile arthritis, unspecified, right ankle and foot M08.972 Juvenile arthritis, unspecified, left ankle and foot M08.979 Juvenile arthritis, unspecified, unspecified ankle and foot M08.98 Juvenile arthritis, unspecified, vertebrae M08.99 Juvenile arthritis, unspecified, multiple sites

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes HCPCS codes: Code Description J1745 Injection, infliximab, 10 mg (Remicade®) Q5102 Injection, Infliximab, Biosimilar, 10 mg Q5103 Injection, infliximab-dyyb, biosimilar, (Inflectra), 10 mg Q5104 Injection, infliximab-abda, biosimilar, (Renflexis), 10 mg

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

Page 52: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description K50.00 Crohn's disease of small intestine without complications K50.011 Crohn's disease of small intestine with rectal bleeding K50.012 Crohn's disease of small intestine with intestinal obstruction K50.013 Crohn's disease of small intestine with fistula K50.014 Crohn's disease of small intestine with abscess K50.018 Crohn's disease of small intestine with other complication K50.019 Crohn's disease of small intestine with unspecified complications K50.10 Crohn's disease of large intestine without complications K50.111 Crohn's disease of large intestine with rectal bleeding K50.112 Crohn's disease of large intestine with intestinal obstruction K50.113 Crohn's disease of large intestine with fistula K50.114 Crohn's disease of large intestine with abscess K50.118 Crohn's disease of large intestine with other complication K50.119 Crohn's disease of large intestine with unspecified complications K50.80 Crohn's disease of both small and large intestine without complications K50.811 Crohn's disease of both small and large intestine with rectal bleeding K50.812 Crohn's disease of both small and large intestine with intestinal obstruction K50.813 Crohn's disease of both small and large intestine with fistula K50.814 Crohn's disease of both small and large intestine with abscess K50.818 Crohn's disease of both small and large intestine with other complication K50.819 Crohn's disease of both small and large intestine with unspecified complications K50.90 Crohn's disease, unspecified, without complications K50.911 Crohn's disease, unspecified, with rectal bleeding K50.912 Crohn's disease, unspecified, with intestinal obstruction K50.913 Crohn's disease, unspecified, with fistula K50.914 Crohn's disease, unspecified, with abscess K50.918 Crohn's disease, unspecified, with other complication K50.919 Crohn's disease, unspecified, with unspecified complications K51.00 Ulcerative (Chronic) Pancolitis Without Complications K51.011 Ulcerative (Chronic) Pancolitis With Rectal Bleeding K51.012 Ulcerative (Chronic) Pancolitis With Intestinal Obstruction K51.013 Ulcerative (Chronic) Pancolitis With Fistula K51.014 Ulcerative (Chronic) Pancolitis With Abscess K51.018 Ulcerative (Chronic) Pancolitis With Other Complication K51.019 Ulcerative (Chronic) Pancolitis With Unspecified Complications K51.20 Ulcerative (Chronic) Proctitis Without Complications K51.211 Ulcerative (Chronic) Proctitis With Rectal Bleeding K51.212 Ulcerative (Chronic) Proctitis With Intestinal Obstruction K51.213 Ulcerative (Chronic) Proctitis With Fistula K51.214 Ulcerative (Chronic) Proctitis With Abscess K51.218 Ulcerative (Chronic) Proctitis With Other Complication K51.219 Ulcerative (Chronic) Proctitis With Unspecified Complications K51.30 Ulcerative (Chronic) Rectosigmoiditis Without Complications K51.311 Ulcerative (Chronic) Rectosigmoiditis With Rectal Bleeding K51.312 Ulcerative (Chronic) Rectosigmoiditis With Intestinal Obstruction K51.313 Ulcerative (Chronic) Rectosigmoiditis With Fistula K51.314 Ulcerative (Chronic) Rectosigmoiditis With Abscess K51.318 Ulcerative (Chronic) Rectosigmoiditis With Other Complication K51.319 Ulcerative (Chronic) Rectosigmoiditis With Unspecified Complications K51.40 Inflammatory Polyps Of Colon Without Complications K51.411 Inflammatory Polyps Of Colon With Rectal Bleeding K51.412 Inflammatory Polyps Of Colon With Intestinal Obstruction

Page 53: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

K51.413 Inflammatory Polyps Of Colon With Fistula K51.414 Inflammatory Polyps Of Colon With Abscess K51.418 Inflammatory Polyps Of Colon With Other Complication K51.419 Inflammatory Polyps Of Colon With Unspecified Complications K51.50 Left Sided Colitis Without Complications K51.511 Left Sided Colitis With Rectal Bleeding K51.512 Left Sided Colitis With Intestinal Obstruction K51.513 Left Sided Colitis With Fistula K51.514 Left Sided Colitis With Abscess K51.518 Left Sided Colitis With Other Complication K51.519 Left Sided Colitis With Unspecified Complications K51.80 Other Ulcerative Colitis Without Complications K51.80 Other Ulcerative Colitis Without Complications K51.811 Other Ulcerative Colitis With Rectal Bleeding K51.812 Other Ulcerative Colitis With Intestinal Obstruction K51.813 Other Ulcerative Colitis With Fistula K51.814 Other Ulcerative Colitis With Abscess K51.818 Other Ulcerative Colitis With Other Complication K51.819 Other Ulcerative Colitis With Unspecified Complications K51.90 Ulcerative Colitis, Unspecified, Without Complications K51.911 Ulcerative Colitis, Unspecified With Rectal Bleeding K51.912 Ulcerative Colitis, Unspecified With Intestinal Obstruction K51.913 Ulcerative Colitis, Unspecified With Fistula K51.914 Ulcerative Colitis, Unspecified With Abscess K51.918 Ulcerative Colitis, Unspecified With Other Complication K51.919 Ulcerative Colitis, Unspecified With Unspecified Complications L40.0 Psoriasis vulgaris L40.50 Arthropathic psoriasis, unspecified L40.51 Distal interphalangeal psoriatic arthropathy L40.52 Psoriatic arthritis mutilans L40.59 Other psoriatic arthropathy M05.00 Felty's syndrome, unspecified site M05.011 Felty's syndrome, right shoulder M05.012 Felty's syndrome, left shoulder M05.019 Felty's syndrome, unspecified shoulder M05.021 Felty's syndrome, right elbow M05.022 Felty's syndrome, left elbow M05.029 Felty's syndrome, unspecified elbow M05.031 Felty's syndrome, right wrist M05.032 Felty's syndrome, left wrist M05.039 Felty's syndrome, unspecified wrist M05.041 Felty's syndrome, right hand M05.042 Felty's syndrome, left hand M05.049 Felty's syndrome, unspecified hand M05.051 Felty's syndrome, right hip M05.052 Felty's syndrome, left hip M05.059 Felty's syndrome, unspecified hip M05.061 Felty's syndrome, right knee M05.062 Felty's syndrome, left knee M05.069 Felty's syndrome, unspecified knee M05.071 Felty's syndrome, right ankle and foot M05.072 Felty's syndrome, left ankle and foot M05.079 Felty's syndrome, unspecified ankle and foot M05.09 Felty's syndrome, multiple sites M05.20 Rheumatoid vasculitis with rheumatoid arthritis of unspecified site M05.211 Rheumatoid vasculitis with rheumatoid arthritis of right shoulder

Page 54: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.212 Rheumatoid vasculitis with rheumatoid arthritis of left shoulder M05.219 Rheumatoid vasculitis with rheumatoid arthritis of unspecified shoulder M05.221 Rheumatoid vasculitis with rheumatoid arthritis of right elbow M05.222 Rheumatoid vasculitis with rheumatoid arthritis of left elbow M05.229 Rheumatoid vasculitis with rheumatoid arthritis of unspecified elbow M05.231 Rheumatoid vasculitis with rheumatoid arthritis of right wrist M05.232 Rheumatoid vasculitis with rheumatoid arthritis of left wrist M05.239 Rheumatoid vasculitis with rheumatoid arthritis of unspecified wrist M05.241 Rheumatoid vasculitis with rheumatoid arthritis of right hand M05.242 Rheumatoid vasculitis with rheumatoid arthritis of left hand M05.249 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hand M05.251 Rheumatoid vasculitis with rheumatoid arthritis of right hip M05.252 Rheumatoid vasculitis with rheumatoid arthritis of left hip M05.259 Rheumatoid vasculitis with rheumatoid arthritis of unspecified hip M05.261 Rheumatoid vasculitis with rheumatoid arthritis of right knee M05.262 Rheumatoid vasculitis with rheumatoid arthritis of left knee M05.269 Rheumatoid vasculitis with rheumatoid arthritis of unspecified knee M05.271 Rheumatoid vasculitis with rheumatoid arthritis of right ankle and foot M05.272 Rheumatoid vasculitis with rheumatoid arthritis of left ankle and foot M05.279 Rheumatoid vasculitis with rheumatoid arthritis of unspecified ankle and foot M05.29 Rheumatoid vasculitis with rheumatoid arthritis of multiple sites M05.30 Rheumatoid heart disease with rheumatoid arthritis of unspecified site M05.311 Rheumatoid heart disease with rheumatoid arthritis of right shoulder M05.312 Rheumatoid heart disease with rheumatoid arthritis of left shoulder M05.319 Rheumatoid heart disease with rheumatoid arthritis of unspecified shoulder M05.321 Rheumatoid heart disease with rheumatoid arthritis of right elbow M05.322 Rheumatoid heart disease with rheumatoid arthritis of left elbow M05.329 Rheumatoid heart disease with rheumatoid arthritis of unspecified elbow M05.331 Rheumatoid heart disease with rheumatoid arthritis of right wrist M05.332 Rheumatoid heart disease with rheumatoid arthritis of left wrist M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist M05.341 Rheumatoid heart disease with rheumatoid arthritis of right hand M05.342 Rheumatoid heart disease with rheumatoid arthritis of left hand M05.349 Rheumatoid heart disease with rheumatoid arthritis of unspecified hand M05.351 Rheumatoid heart disease with rheumatoid arthritis of right hip M05.352 Rheumatoid heart disease with rheumatoid arthritis of left hip M05.359 Rheumatoid heart disease with rheumatoid arthritis of unspecified hip M05.361 Rheumatoid heart disease with rheumatoid arthritis of right knee M05.362 Rheumatoid heart disease with rheumatoid arthritis of left knee M05.369 Rheumatoid heart disease with rheumatoid arthritis of unspecified knee M05.371 Rheumatoid heart disease with rheumatoid arthritis of right ankle and foot M05.372 Rheumatoid heart disease with rheumatoid arthritis of left ankle and foot M05.379 Rheumatoid heart disease with rheumatoid arthritis of unspecified ankle and foot M05.39 Rheumatoid heart disease with rheumatoid arthritis of multiple sites M05.40 Rheumatoid myopathy with rheumatoid arthritis of unspecified site M05.411 Rheumatoid myopathy with rheumatoid arthritis of right shoulder M05.412 Rheumatoid myopathy with rheumatoid arthritis of left shoulder M05.419 Rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder M05.421 Rheumatoid myopathy with rheumatoid arthritis of right elbow M05.422 Rheumatoid myopathy with rheumatoid arthritis of left elbow M05.429 Rheumatoid myopathy with rheumatoid arthritis of unspecified elbow M05.431 Rheumatoid myopathy with rheumatoid arthritis of right wrist M05.432 Rheumatoid myopathy with rheumatoid arthritis of left wrist M05.439 Rheumatoid myopathy with rheumatoid arthritis of unspecified wrist M05.441 Rheumatoid myopathy with rheumatoid arthritis of right hand M05.442 Rheumatoid myopathy with rheumatoid arthritis of left hand

Page 55: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.449 Rheumatoid myopathy with rheumatoid arthritis of unspecified hand M05.451 Rheumatoid myopathy with rheumatoid arthritis of right hip M05.452 Rheumatoid myopathy with rheumatoid arthritis of left hip M05.459 Rheumatoid myopathy with rheumatoid arthritis of unspecified hip M05.461 Rheumatoid myopathy with rheumatoid arthritis of right knee M05.462 Rheumatoid myopathy with rheumatoid arthritis of left knee M05.469 Rheumatoid myopathy with rheumatoid arthritis of unspecified knee M05.471 Rheumatoid myopathy with rheumatoid arthritis of right ankle and foot M05.472 Rheumatoid myopathy with rheumatoid arthritis of left ankle and foot M05.479 Rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot M05.49 Rheumatoid myopathy with rheumatoid arthritis of multiple sites M05.50 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified site M05.511 Rheumatoid polyneuropathy with rheumatoid arthritis of right shoulder M05.512 Rheumatoid polyneuropathy with rheumatoid arthritis of left shoulder M05.519 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified shoulder M05.521 Rheumatoid polyneuropathy with rheumatoid arthritis of right elbow M05.522 Rheumatoid polyneuropathy with rheumatoid arthritis of left elbow M05.529 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified elbow M05.531 Rheumatoid polyneuropathy with rheumatoid arthritis of right wrist M05.532 Rheumatoid polyneuropathy with rheumatoid arthritis of left wrist M05.539 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified wrist M05.541 Rheumatoid polyneuropathy with rheumatoid arthritis of right hand M05.542 Rheumatoid polyneuropathy with rheumatoid arthritis of left hand M05.549 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hand M05.551 Rheumatoid polyneuropathy with rheumatoid arthritis of right hip M05.552 Rheumatoid polyneuropathy with rheumatoid arthritis of left hip M05.559 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip M05.561 Rheumatoid polyneuropathy with rheumatoid arthritis of right knee M05.562 Rheumatoid polyneuropathy with rheumatoid arthritis of left knee M05.569 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified knee M05.571 Rheumatoid polyneuropathy with rheumatoid arthritis of right ankle and foot M05.572 Rheumatoid polyneuropathy with rheumatoid arthritis of left ankle and foot M05.579 Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified ankle and foot M05.59 Rheumatoid polyneuropathy with rheumatoid arthritis of multiple sites M05.60 Rheumatoid arthritis of unspecified site with involvement of other organs and systems M05.611 Rheumatoid arthritis of right shoulder with involvement of other organs and systems M05.612 Rheumatoid arthritis of left shoulder with involvement of other organs and systems

M05.619 Rheumatoid arthritis of unspecified shoulder with involvement of other organs and systems

M05.621 Rheumatoid arthritis of right elbow with involvement of other organs and systems M05.622 Rheumatoid arthritis of left elbow with involvement of other organs and systems

M05.629 Rheumatoid arthritis of unspecified elbow with involvement of other organs and systems

M05.631 Rheumatoid arthritis of right wrist with involvement of other organs and systems M05.632 Rheumatoid arthritis of left wrist with involvement of other organs and systems M05.639 Rheumatoid arthritis of unspecified wrist with involvement of other organs and systems M05.641 Rheumatoid arthritis of right hand with involvement of other organs and systems M05.642 Rheumatoid arthritis of left hand with involvement of other organs and systems M05.649 Rheumatoid arthritis of unspecified hand with involvement of other organs and systems M05.651 Rheumatoid arthritis of right hip with involvement of other organs and systems M05.652 Rheumatoid arthritis of left hip with involvement of other organs and systems M05.659 Rheumatoid arthritis of unspecified hip with involvement of other organs and systems M05.661 Rheumatoid arthritis of right knee with involvement of other organs and systems M05.662 Rheumatoid arthritis of left knee with involvement of other organs and systems M05.669 Rheumatoid arthritis of unspecified knee with involvement of other organs and systems M05.671 Rheumatoid arthritis of right ankle and foot with involvement of other organs and

Page 56: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

systems

M05.672 Rheumatoid arthritis of left ankle and foot with involvement of other organs and systems

M05.679 Rheumatoid arthritis of unspecified ankle and foot with involvement of other organs and systems

M05.69 Rheumatoid arthritis of multiple sites with involvement of other organs and systems

M05.70 Rheumatoid arthritis with rheumatoid factor of unspecified site without organ or systems involvement

M05.711 Rheumatoid arthritis with rheumatoid factor of right shoulder without organ or systems involvement

M05.712 Rheumatoid arthritis with rheumatoid factor of left shoulder without organ or systems involvement

M05.719 Rheumatoid arthritis with rheumatoid factor of unspecified shoulder without organ or systems involvement

M05.721 Rheumatoid arthritis with rheumatoid factor of right elbow without organ or systems involvement

M05.722 Rheumatoid arthritis with rheumatoid factor of left elbow without organ or systems involvement

M05.729 Rheumatoid arthritis with rheumatoid factor of unspecified elbow without organ or systems involvement

M05.731 Rheumatoid arthritis with rheumatoid factor of right wrist without organ or systems involvement

M05.732 Rheumatoid arthritis with rheumatoid factor of left wrist without organ or systems involvement

M05.739 Rheumatoid arthritis with rheumatoid factor of unspecified wrist without organ or systems involvement

M05.741 Rheumatoid arthritis with rheumatoid factor of right hand without organ or systems involvement

M05.742 Rheumatoid arthritis with rheumatoid factor of left hand without organ or systems involvement

M05.749 Rheumatoid arthritis with rheumatoid factor of unspecified hand without organ or systems involvement

M05.751 Rheumatoid arthritis with rheumatoid factor of right hip without organ or systems involvement

M05.752 Rheumatoid arthritis with rheumatoid factor of left hip without organ or systems involvement

M05.759 Rheumatoid arthritis with rheumatoid factor of unspecified hip without organ or systems involvement

M05.761 Rheumatoid arthritis with rheumatoid factor of right knee without organ or systems involvement

M05.762 Rheumatoid arthritis with rheumatoid factor of left knee without organ or systems involvement

M05.769 Rheumatoid arthritis with rheumatoid factor of unspecified knee without organ or systems involvement

M05.771 Rheumatoid arthritis with rheumatoid factor of right ankle and foot without organ or systems involvement

M05.772 Rheumatoid arthritis with rheumatoid factor of left ankle and foot without organ or systems involvement

M05.779 Rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot without organ or systems involvement

M05.79 Rheumatoid arthritis with rheumatoid factor of multiple sites without organ or systems involvement

M05.80 Other rheumatoid arthritis with rheumatoid factor of unspecified site M05.811 Other rheumatoid arthritis with rheumatoid factor of right shoulder M05.812 Other rheumatoid arthritis with rheumatoid factor of left shoulder M05.819 Other rheumatoid arthritis with rheumatoid factor of unspecified shoulder M05.821 Other rheumatoid arthritis with rheumatoid factor of right elbow M05.822 Other rheumatoid arthritis with rheumatoid factor of left elbow M05.829 Other rheumatoid arthritis with rheumatoid factor of unspecified elbow

Page 57: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M05.831 Other rheumatoid arthritis with rheumatoid factor of right wrist M05.832 Other rheumatoid arthritis with rheumatoid factor of left wrist M05.839 Other rheumatoid arthritis with rheumatoid factor of unspecified wrist M05.841 Other rheumatoid arthritis with rheumatoid factor of right hand M05.842 Other rheumatoid arthritis with rheumatoid factor of left hand M05.849 Other rheumatoid arthritis with rheumatoid factor of unspecified hand M05.851 Other rheumatoid arthritis with rheumatoid factor of right hip M05.852 Other rheumatoid arthritis with rheumatoid factor of left hip M05.859 Other rheumatoid arthritis with rheumatoid factor of unspecified hip M05.861 Other rheumatoid arthritis with rheumatoid factor of right knee M05.862 Other rheumatoid arthritis with rheumatoid factor of left knee M05.869 Other rheumatoid arthritis with rheumatoid factor of unspecified knee M05.871 Other rheumatoid arthritis with rheumatoid factor of right ankle and foot M05.872 Other rheumatoid arthritis with rheumatoid factor of left ankle and foot M05.879 Other rheumatoid arthritis with rheumatoid factor of unspecified ankle and foot M05.89 Other rheumatoid arthritis with rheumatoid factor of multiple sites M05.9 Rheumatoid arthritis with rheumatoid factor, unspecified M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site M06.011 Rheumatoid arthritis without rheumatoid factor, right shoulder M06.012 Rheumatoid arthritis without rheumatoid factor, left shoulder M06.019 Rheumatoid arthritis without rheumatoid factor, unspecified shoulder M06.021 Rheumatoid arthritis without rheumatoid factor, right elbow M06.022 Rheumatoid arthritis without rheumatoid factor, left elbow M06.029 Rheumatoid arthritis without rheumatoid factor, unspecified elbow M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist M06.039 Rheumatoid arthritis without rheumatoid factor, unspecified wrist M06.041 Rheumatoid arthritis without rheumatoid factor, right hand M06.042 Rheumatoid arthritis without rheumatoid factor, left hand M06.049 Rheumatoid arthritis without rheumatoid factor, unspecified hand M06.051 Rheumatoid arthritis without rheumatoid factor, right hip M06.052 Rheumatoid arthritis without rheumatoid factor, left hip M06.059 Rheumatoid arthritis without rheumatoid factor, unspecified hip M06.061 Rheumatoid arthritis without rheumatoid factor, right knee M06.062 Rheumatoid arthritis without rheumatoid factor, left knee M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee M06.071 Rheumatoid arthritis without rheumatoid factor, right ankle and foot M06.072 Rheumatoid arthritis without rheumatoid factor, left ankle and foot M06.079 Rheumatoid arthritis without rheumatoid factor, unspecified ankle and foot M06.08 Rheumatoid arthritis without rheumatoid factor, vertebrae M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites M06.1 Adult-onset Still's disease M06.80 Other specified rheumatoid arthritis, unspecified site M06.811 Other specified rheumatoid arthritis, right shoulder M06.812 Other specified rheumatoid arthritis, left shoulder M06.819 Other specified rheumatoid arthritis, unspecified shoulder M06.821 Other specified rheumatoid arthritis, right elbow M06.822 Other specified rheumatoid arthritis, left elbow M06.829 Other specified rheumatoid arthritis, unspecified elbow M06.831 Other specified rheumatoid arthritis, right wrist M06.832 Other specified rheumatoid arthritis, left wrist M06.839 Other specified rheumatoid arthritis, unspecified wrist M06.841 Other specified rheumatoid arthritis, right hand M06.842 Other specified rheumatoid arthritis, left hand M06.849 Other specified rheumatoid arthritis, unspecified hand M06.851 Other specified rheumatoid arthritis, right hip

Page 58: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

M06.852 Other specified rheumatoid arthritis, left hip M06.859 Other specified rheumatoid arthritis, unspecified hip M06.861 Other specified rheumatoid arthritis, right knee M06.862 Other specified rheumatoid arthritis, left knee M06.869 Other specified rheumatoid arthritis, unspecified knee M06.871 Other specified rheumatoid arthritis, right ankle and foot M06.872 Other specified rheumatoid arthritis, left ankle and foot M06.879 Other specified rheumatoid arthritis, unspecified ankle and foot M06.88 Other specified rheumatoid arthritis, vertebrae M06.89 Other specified rheumatoid arthritis, multiple sites M06.9 Rheumatoid arthritis, unspecified M45.0 Ankylosing spondylitis of multiple sites in spine M45.1 Ankylosing spondylitis of occipito-atlanto-axial region M45.2 Ankylosing spondylitis of cervical region M45.3 Ankylosing spondylitis of cervicothoracic region M45.4 Ankylosing spondylitis of thoracic region M45.5 Ankylosing spondylitis of thoracolumbar region M45.6 Ankylosing spondylitis lumbar region M45.7 Ankylosing spondylitis of lumbosacral region M45.8 Ankylosing spondylitis sacral and sacrococcygeal region M45.9 Ankylosing spondylitis of unspecified sites in spine

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes HCPCS codes: Code Description J3357 Injection,, ustekinumab, 1 mg (Stelara™) J3358 Ustekinumab, for intravenous injection, 1 mg (Stelara™)

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met: ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description K50.00 Crohn's disease of small intestine without complications K50.011 Crohn's disease of small intestine with rectal bleeding K50.012 Crohn's disease of small intestine with intestinal obstruction K50.013 Crohn's disease of small intestine with fistula K50.014 Crohn's disease of small intestine with abscess K50.018 Crohn's disease of small intestine with other complication K50.019 Crohn's disease of small intestine with unspecified complications K50.10 Crohn's disease of large intestine without complications K50.111 Crohn's disease of large intestine with rectal bleeding K50.112 Crohn's disease of large intestine with intestinal obstruction K50.113 Crohn's disease of large intestine with fistula K50.114 Crohn's disease of large intestine with abscess K50.118 Crohn's disease of large intestine with other complication K50.119 Crohn's disease of large intestine with unspecified complications K50.80 Crohn's disease of both small and large intestine without complications K50.811 Crohn's disease of both small and large intestine with rectal bleeding K50.812 Crohn's disease of both small and large intestine with intestinal obstruction K50.813 Crohn's disease of both small and large intestine with fistula

Page 59: 004 Immune Modulating Drugs - Blue Cross Blue Shield of ......Policy Number: 004 . BCBSA Reference Number: 5.01.15 . Related Policies • Quality Care Dosing guidelines may apply to

K50.814 Crohn's disease of both small and large intestine with abscess K50.818 Crohn's disease of both small and large intestine with other complication K50.819 Crohn's disease of both small and large intestine with unspecified complications K50.90 Crohn's disease, unspecified, without complications K50.911 Crohn's disease, unspecified, with rectal bleeding K50.912 Crohn's disease, unspecified, with intestinal obstruction K50.913 Crohn's disease, unspecified, with fistula K50.914 Crohn's disease, unspecified, with abscess K50.918 Crohn's disease, unspecified, with other complication K50.919 Crohn's disease, unspecified, with unspecified complications L40.0 Psoriasis vulgaris L40.50 Arthropathic psoriasis, unspecified L40.51 Distal interphalangeal psoriatic arthropathy L40.52 Psoriatic arthritis mutilans L40.59 Other psoriatic arthropathy

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes HCPCS codes: Code Description J0638 Injection, canakinumab, 1 mg (Ilaris ®)

The above medical necessity criteria MUST be met for the following codes to be covered for Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity:

HCPCS Codes HCPCS codes: Code Description J1628 Injection, guselkumab, 1 mg J3245 Injection, tildrakizumab, 1 mg

The following ICD Diagnosis Codes are considered medically necessary when submitted with the HCPCS code above if medical necessity criteria are met:

ICD-10 Diagnosis Codes ICD-10-CM Diagnosis codes: Code Description L40.0 Psoriasis vulgaris

Endnotes 1. Traditional DMARD agents include azathioprine, cyclosporine, d-penicillamine, gold sodium thiomalate,

methotrexate, auranofin, aurothioglucose, hydroxychloroquine, leflunomide, and sulfasalazine. 1 2. Biological DMARD agents include Cimzia® (certolizumab), Enbrel® (etanercept), Humira™

(adalimumab), Kineret® (anakinra), Orencia™ (abatacept), Remicade® (infliximab) or Simponi (golimumab). 2

3. Based on the FDA approved labeling in the package insert for Orencia™.3 4. Based on the recommendations of the BCBSMA Pharmacy and Therapeutics Committee meeting on

05/13/2008. 4 5. Based on the recommendations of the BCBSMA Pharmacy and Therapeutics Committee

meeting on 09/15/2009. To request prior authorization using the Massachusetts Standard Form for Medication Prior Authorization Requests (eForm), click the link below: http://www.bluecrossma.com/common/en_US/medical_policies/023%20E%20Form%20medication%20prior%20auth%20instruction%20prn.pdf